In Press
Akinwolere, O.G., Schwartz, R.P. (In Press). The Relationship between Vaping Cannabis and Frequency of Cannabis Use and Cannabis-Related Problems Among Urban High School Students. Substance Use and Misuse.
Carswell, S.B., Alexander, K., Gryczynski, J., Knowlton, A.R., Abatemarco, D.J., Horodyski, A.M., & Mitchell, M.M. (In Press). Mindfulness-based mobile application for African American caregivers. Journal of Technology in Behavioral Science.
Hochstatter, K.R., Williams, M., Latham, S., Fenton, D., Falzon, A.L. (In Press). Rapid Identification of Suspected Overdose Deaths by Death Investigators. Public Health Reports.
Sawyer-Morris, G., Wilde, J., Molfenter, T., & Taxman, F. (In Press). Use of digital health and digital therapeutics to treat sud in criminal justice settings: A review. Current Addiction Reports.
Wartko, P.D., Bobb, J.F., Boudreau, D.M., Matthews, A.G., McCormack, J., Lee, A.K., Qiu, H., Yu. O., Hyun, N., Idu, A.E., Campbell, C.I., Saxon, A.J., Liu, D.S., Altschuler, A., Samet, J.H., Labelle, C.T., Zare-Mahrjerdi, A., Stotts, A.L., Braciszewski, J.M., Murphy, M.T., Dryden, D., Arnsten, J.H., Cunningham, C.O., Horigian, V.E., Szapocznik, J., Glass, J.E., Caldeiro, R.M., Phillips, R.C., Shea, M., Bart, G., Schwartz, R.P., McNeely, J., Liebschutz, J.M., Tsui, J.I., Merrill, J.O., Lapham, G.T., Addis, M., Bradley, K.A., PROUD Trial Collaborators. (In Press). The Primary Care Opioid Use Disorders treatment (PROUD) trial: a cluster-randomized implementation trial of nurse care management for opioid use disorder treatment. JAMA Internal Medicine.
2023
Alexander K. & Terplan, M. (2023). Contingency Management: Promises, Gaps, and Philosophical Limitations. The American Journal of Accountable Care
(AJAC),11(2):28-29. https://doi.org/10.37765/ajac.2023.89382.
Alexander K., Nordeck, C., Rosecrans, A., Harris, R., Collins, A., Gryczynski, J. (2023). Perspectives of people experiencing homelessness on the effect of a non-congregate, integrated care shelter on health: a qualitative study. Public Health Nursing.
00, 1– 10. https://doi.org/10.1111/phn.13197.
Alexander K., Reed, M., Sterling, R. (2023). The interaction of race and age in methadone treatment retention outcomes: a single-center analysis. Journal of Substance Use and Addiction Treatment.
doi: 10.1016/j.josat.2023.209020. Epub 2023 Mar 16. PubMed PMID: 36933661.
Alexander K., Sanjuan, P., Terplan, M. (2023). How has ecological momentary assessment been used with people in medication-based treatment for opioid use disorder? Current Addiction Reports.
[Epub ahead of print]. https://doi.org/10.1007/s40429-023-00492-5.
Alexander K., Smith, J., Gerolamo, A., Bernhardt, J. (2023). The impact of nursing on health outcomes of people receiving medication for opioid use disorder. Journal of Nursing Scholarship,
00, 1– 9. https://doi.org/10.1111/jnu.12858.
Alexander, K., & Clary-Muronda, V. (2023). A scoping review of interventions seeking to improve aspects of patient-provider relationships involving Black pregnant and post-partum people. . J Adv Nurs, 79
(5), 2014-2024. https://doi.org/10.1111/jan.15537.
Alexander, K., Nordeck, C. D., Rosecrans, A., Harris, R., Collins, A., & Gryczynski, J. (2023). The effect of a non-congregate, integrated care shelter on health: A qualitative study. Public Health Nurs, 40
(4), 487-496. https://doi.org/10.1111/phn.13197.
Alexander, K., Reed, M. K., & Sterling, R. C. (2023). The interaction of race and age in methadone treatment retention outcomes: A single-center analysis. J Subst Use Addict Treat, 148,
209020. https://doi.org/10.1016/j.josat.2023.209020.
Alexander, K., Smith, J. M., Gerolamo, A., & Bernhardt, J. (2023). The impact of nursing on health outcomes of people receiving medication for opioid use disorder: An integrative review. J Nurs Scholarsh, 55
(3), 721-729. https://doi.org/10.1111/jnu.12858.
Appleton, C., Smith, L., & Rudes, D. S. (2023). Actionable MI: Gendered Perceptions of Probation Officer-Client Relationships. Journal of Qualitative Criminal Justice and Criminology.
Barber, C. M., & Terplan, M. (2023). Principles of care for pregnant and parenting people with substance use disorder: the obstetrician gynecologist perspective. Front Pediatr, 11,
1045745. https://doi.org/10.3389/fped.2023.1045745.
Blue, T. R., Fletcher, J. B., Monico, L. B., Gordon, M. S., Schwartz, R. P., & Mitchell, S. G. (2023). Jail and treatment staff attitudes regarding MOUDs before and after an implementation intervention. Journal of Offender Rehabilitation, 62
(7), 411-426. https://doi.org/10.1080/10509674.2023.2246446.
Bunting, A. M., Schwartz, R. P., Wu, L. T., Wahle, A., Kline, M., Subramaniam, G., & McNeely, J (2023). A Brief Screening and Assessment Tool for Opioid Use in Adults: Results from a Validation Study of the Tobacco, Alcohol, Prescription Medication, and Other Substances Tool. J Addict Med, 17
(4), 471-473. https://doi.org/10.1097/ADM.0000000000001139.
Burruss-Cousins, K., Harmon-Darrow, C., Mallon, N., McTavish, G., & Finigan-Carr, N. (2023). Experiences of Child Welfare Workers in a Child Sex Trafficking Training. Journal of Human Trafficking,
1-15.
Carswell, S. B., Gordon, M. S., Gryczynski, J., Horodyski, A. M., Ferguson, K. N., Maher, K. M., & Vocci, F. J. (2023). The daily progress system – a recovery support tool to improve engagement and retention in outpatient substance use treatment. Journal of Substance Use,
1-6. https://doi.org/10.1080/14659891.2023.2261036.
Cohen, S., Nielsen, T., Chou, J. H., Hoeppner, B., Koenigs, K. J., Bernstein, S. N., Smith, N. A., Perlman, N., Sarathy, L., Wilens, T., Terplan, M., & Schiff, D. M. (2023). Disparities in Maternal-Infant Drug Testing, Social Work Assessment, and Custody at 5 Hospitals. Acad Pediatr, 23
(6), 1268-1275. https://doi.org/10.1016/j.acap.2023.01.012.
D’Onofrio, G., Edelman, E. J., Hawk, K. F., Chawarski, M. C., Pantalon, M. V., Owens, P. H., Martel, S. H., Rothman, R., Saheed, M., Schwartz, R. P., Cowan, E., Richardson, L., Salsitz, E., Lyons, M. S., Freiermuth, C., Wilder, C., Whiteside, L., Tsui, J. I., Klein, J. W., . . . Fiellin, D. A. (2023). Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder. JAMA Netw Open, 6
(4), e235439. https://doi.org/10.1001/jamanetworkopen.2023.5439.
Darlington, C. K., Clark, R., Jacoby, S. F., Terplan, M., Alexander, K., & Compton, P. (2023). Outcomes and experiences after child custody loss among mothers who use drugs: A mixed studies systematic review. Drug Alcohol Depend, 251,
110944. https://doi.org/10.1016/j.drugalcdep.2023.110944.
Darlington, C., Clark, R., Jacoby, S., Terplan M., Alexander K., Compton, P. (2023). Outcomes and Experiences After Child Custody Loss Among Mothers Who Use Drugs: A Mixed Studies Systematic Review. Drug and Alcohol Dependence.
251,110944.
DeSisto, C. L., Terplan, M., Kacha-Ochana, A., Green, J. L., Mueller, T., Cox, S., & Ko, J. Y. (2023). Buprenorphine use and setting type among reproductive-aged women self-reporting nonmedical prescription opioid use. J Subst Use Addict Treat,
209083. https://doi.org/10.1016/j.josat.2023.209083.
Edwards, F., Roberts, S. C. M., Kenny, K. S., Raz, M., Lichtenstein, M., & Terplan, M. (2023). Medical Professional Reports and Child Welfare System Infant Investigations: An Analysis of National Child Abuse and Neglect Data System Data. Health Equity, 7
(1), 653-662. https://doi.org/10.1089/heq.2023.0136.
Gelberg, K. H., Chase, R., Lindstrom, M., Hochstatter, K. R., Larochelle, L., & Hunt, T. ( (2023). Need for Improved Timeliness of Reporting on Drug Overdose Fatalities: The HEALing Communities Study. Public Health Rep,
333549231161339. https://doi.org/10.1177/00333549231161339.
Giang, L. M., Trang, N. T., Thuy, D. T., Nguyen, H. H., Diep, N. B., Van, H. T. H., Truc, T. T., Reback, C. J., Li, M., Van Dung, D., & Shoptaw, S. (2023). Using ADAPT-ITT framework to tailor evidence-based interventions for addressing methamphetamine use among methadone patients in Vietnam. Drug Alcohol Rev.
https://doi.org/10.1111/dar.13739.
Glasner, S., Wei, A. X., Ryan, P. C., Michero, D. N., Monico, L. B., Pielsticker, P. E., & Horowitz, L. M. (2023). Implementing Suicide Risk Screening in a Virtual Addiction Clinic. Community Ment Health J.
https://doi.org/10.1007/s10597-023-01181-3.
Gryczynski, J., Mitchell, S. G., Asche, S. E., Truitt, A. R., Worley, D. C., & Rindal, D. B. ( (2023). De-Implementing Opioids for Dental Extractions (DIODE): a multi-clinic, cluster-randomized trial of clinical decision support strategies in dentistry. Implement Sci, 18
(1), 5. https://doi.org/10.1186/s13012-023-01262-7.
Gryczynski, J., Monico, L. B., Garrison, K., Dusek, K., Oros, M., Hosler, C., Brown, B. S., Schwartz, R. P., O’Grady, K. E., Kirk, A., & Mitchell, S. G. (2023). Sustainability of Adolescent Screening and Brief Intervention Services in Primary Care After Removal of Implementation Supports. J Stud Alcohol Drugs, 84
(1), 103-108. https://doi.org/10.15288/jsad.21-00324.
Harmon-Darrow, C., Rubenstein, A., Burruss-Cousins, K., McTavish, G., Eisler, A., & Finigan-Carr, N. (2023). Engaging Victims of Child Sex Trafficking: Training for Child Welfare Workers. Social Work Research.
https://doi.org/https://doi.org/10.1093/swr/svad008.
Hochstatter, K. R., Nordeck, C., Mitchell, S. G., Schwartz, R. P., Welsh, C., & Gryczynski, J. (2023). Polysubstance use and post-discharge mortality risk among hospitalized patients with opioid use disorder. Preventive Medicine Reports, 36,
102494. https://doi.org/https://doi.org/10.1016/j.pmed r.2023.102494.
Hogue, A., Satcher, M. F., Drazdowski, T. K., Hagaman, A., Hibbard, P. F., Sheidow, A. J., Coetzer-Liversagef, A., Mitchell, S. G., Watson, D. P., Wilson, K. J., Muench, F., Fishman, M., Wenzel, K., de Martell, S. C., & Stein, L. A. R. (2023). Linkage facilitation services for opioid use disorder: Taxonomy of facilitation practitioners, goals, and activities. J Subst Use Addict Treat,
209217. https://doi.org/10.1016/j.josat.2023.209217.
Hulsey, J., Zawislak, K., Sawyer-Morris, G., & Earnshaw, V. (2023). Stigmatizing imagery for substance use disorders: a qualitative exploration. Health & Justice,
11(1), 28. https://doi.org/10.1186/s40352-02300229-6.
Jain, J. P., Hill, M., Gamarel, K. E., Santos, G. M., Johnson, M. O., Neilands, T. B., Dilworth, S. E., Reback, C. J., & Sevelius, J. (2023). Socio-ecological Barriers to Viral Suppression Among Transgender Women Living with HIV in San Francisco and Los Angeles, California. AIDS and behavior, 27
(8), 2523-2534. https://doi.org/https://doi.org/10.1007/s10461-023-03979-4.
Jarlenski, M., Shroff, J., Terplan, M., Roberts, S. C. M., Brown-Podgorski, B., & Krans, E. E. (2023). Association of Race With Urine Toxicology Testing Among Pregnant Patients During Labor and Delivery. JAMA Health Forum, 4
(4), e230441. https://doi.org/10.1001/jamahealthforum.2023.0441.
Kelty, E., Terplan, M., Orr, C., & Preen, D. B. (2023). Neonatal Outcomes Associated With in Utero Exposure to Oxycodone, Overall and by Trimester of Exposure: A Retrospective Cohort Study. J Pain, 24
(4), 617-626. https://doi.org/10.1016/j.jpain.2022.11.007.
Landis, R. K., Stein, B. D., Griffin, B. A., Saloner, B. K., Terplan, M., & Faherty, L. J. (2023). Disparities in Perinatal and Emergency Care Receipt Among Women With Perinatal Opioid Use Disorder in Medicaid, 2007 to 2012. J Addict Med.
https://doi.org/10.1097/ADM.0000000000001199.
Levy, S., Brogna, M., Minegishi, M., Subramaniam, G., McCormack, J., Kline, M., Menzin, E., Allende-Richter, S., Fuller, A., Lewis, M., Collins, J., Hubbard, Z., Mitchell, S. G., Weiss, R., & Weitzman, E. (2023). Assessment of Screening Tools to Identify Substance Use Disorders Among Adolescents. JAMA Netw Open, 6
(5), e2314422. https://doi.org/10.1001/jamanetworkopen.2023.14422.
Lipsett, M., Wyant-Stein, K., Mendes, S., Berger, E., Berkman, E. T., Terplan, M., & Cioffi, C. C. (2023). Addressing stigma within the dissemination of research products to improve quality of care for pregnant and parenting people affected by substance use disorder. Front Psychiatry, 14,
1199661. https://doi.org/10.3389/fpsyt.2023.1199661.
Lyons, M. S., Chawarski, M. C., Rothman, R., Whiteside, L., Cowan, E., Richardson, L. D., Hawk, K., Tsui, J. I., Schwartz, R. P., O’Connor, P., D’Onofrio, G., Fiellin, D. A., & Edelman, E. J. (2023). Missed Opportunities for HIV and Hepatitis C Screening Among Emergency Department Patients With Untreated Opioid Use Disorder. J Addict Med, 17
(2), 210-214. https://doi.org/10.1097/ADM.0000000000001074.
Marini, C., Northover, N.S., Gold, N.D., Rogers, U.K., O’Donnell, K.C., Tofighi, B., Ross, S., Bogenschutz, M.P. (2023). A Systematic Approach to Standardizing Drinking Outcomes From Timeline Followback Data. Substance Abuse: Research and Treatment
, 17, 11782218231157558.
Mazel, S., Alexander K., Cioffi, C.C., Terplan, M. (2023). Interventions to support engagement in addiction care post-partum: principles and pitfalls. Substance Abuse and Rehabilitation,
14, 49-59, https://doi.org/10.2147/SAR.S375652.
Mazel, S., Alexander, K., Cioffi, C., & Terplan, M. (2023). Interventions to Support Engagement in Addiction Care Postpartum: Principles and Pitfalls. Subst Abuse Rehabil, 14,
49-59. https://doi.org/10.2147/sar.S375652.
Mhonde, R. R. D., Riddick, B., Hingle, A., Shaw, C. Rudes, D.S., Pollack, H., Schneider, J., Zhao, X., & Taxman, F. (2023). “I just don’t know what to believe:” Sensemaking during the COVID-19 pandemic among criminal legal involved communities. International Journal of Environmental Research and Public Health,
19(22), 15045.
Miller, J., Cuby, J., Hall, S. M., Stitzer, M., Kushel, M., Appiah, D., & Vijayaraghavan, M. (2023). Tobacco use behaviors and views on engaging in clinical trials for tobacco cessation among individuals who experience homelessness. Contemp Clin Trials Commun, 32,
101094. https://doi.org/10.1016/j.conctc.2023.101094.
Mitchell, S. G., Fletcher, J. B., Monico, L. B., Gryczynski, J., Fishman, M. J., O’Grady, K. E., & Schwartz, R. P. (2023). Comparing outcomes of extended-release naltrexone in adolescents and young adults with opioid use disorder. J Subst Use Addict Treat,
209162. https://doi.org/10.1016/j.josat.2023.209162.
Mitchell, S. G., Jester, J., Gryczynski, J., Whitter, M., Fuller, D., Halsted, C., & Schwartz, R. P. (2023). Impact of COVID-19-related methadone regulatory flexibilities: views of state opioid treatment authorities and program staff. Addict Sci Clin Pract, 18
(1), 61. https://doi.org/10.1186/s13722-023-00417-7.
Monico, L.B., O’Grady, K.E., Gryczynski, J., Garrison, K., Ross, T., Terplan, M., & Mitchell, S.G. (2023). Substance Use and Mental Health Responses to COVID-19 Among Rural Adolescents. Arch Pediatr,
8: 274. https://doi.org/10.29011/2575-825X.100274.
Orme, S., Zarkin, G. A., Dunlap, L. J., Monico, L. B., Gryczynski, J., Fishman, M. J., Schwartz, R. P., O’Grady, K. E., & Mitchell, S. G. (2023). Health care use and cost of treatment for adolescents and young adults with opioid use disorder. J Subst Use Addict Treat, 154,
209137. https://doi.org/10.1016/j.josat.2023.209137.
Orta Portillo, G. A., Fletcher, J. B., Young, L. E., & Klausner, J. D. (2023). Virtual avatars as a new tool for human immunodeficiency virus prevention among men who have sex with men: a narrative review. Mhealth, 9,
29. https://doi.org/10.21037/mhealth-22-33.
Petrucci, C. (2023). First They Have to Show Up: How Dads Back! Academy Successfully Engaged Formerly Incarcerated Fathers in a Responsible Fatherhood Program. Revista de Investigación en Educación, 21,
114-133. https://doi.org/https://doi.org/10.35869/reined.v21i1.4535.
Pettus, C., Kennedy, S.C., Renn, T., Tripodi, S., Rudes, D.S., & Taxman, F.S. (2023). Behavioral health literacy: A new construct to improve outcomes among incarcerated individuals.
Reback, C. J., Lin, C., Larkins, S., Vi, V. T. T., Diep, N. T. N., Lai, Nguyen L., & Dung, D. V. (2023). Adaptation of the U.S.-oriented evidence-based intervention TransAction for transgender women in Vietnam. International Journal of Transgender Health,
1-18. https://doi.org/10.1080/26895269.2023.2169217.
Rindal, D. B., Gryczynski, J., Asche, S. E., Truitt, A. R., Kane, S. M., Worley, D. C., & Mitchell, S. G. (2023). De-implementing opioid prescribing in a dental group practice: Lessons learned. Community Dent Oral Epidemiol, 51
(1), 139-142. https://doi.org/10.1111/cdoe.12820.
Sarathy, L., Chou, J. H., Lerou, P. H., Terplan, M., Mark, K., Dorfman, S., Wilens, T. E., Bernstein, S. N., & Schiff, D. M. (2023). Limited Utility of Toxicology Testing at Delivery for Perinatal Cannabis Use. Hospital Pediatrics, 13
(4), 317-325. https://doi.org/10.1542/hpeds.2022-006897.
Shram, M. J., Henningfield, J. E., Apseloff, G., Gorodetzky, C. W., De Martin, S., Vocci, F. L., Sapienza, F. L., Kosten, T. R., Huston, J., Buchhalter, A., Ashworth, J., Lanier, R., Folli, F., Mattarei, A., Guidetti, C., Comai, S., O’Gorman, C., Traversa, S., Inturrisi, C. E., Manfredi, P.L., Pappagallo, M. (2023). The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users. Transl Psychiatry, 13
(1), 192. https://doi.org/10.1038/s41398-023-02473-8.
Siegel, M. R., Cohen, S. J., Koenigs, K., Woods, G. T., Schwartz, L. N., Sarathy, L., Chou, J. H., Terplan, M., Wilens, T., Ecker, J. L., Bernstein, S. N., & Schiff, D. M. (2023). Assessing the clinical utility of toxicology testing in the peripartum period. Am J Obstet Gynecol MFM, 5
(7), 100963. https://doi.org/10.1016/j.ajogmf.2023.100963.
Smith, L. R., Faragó, F., Blue, T., Witte, J. C., Gordon, M. S., & Taxman, F. S. (2023). Viewing Then Doing?: Problem-Solving Court Coordinators’ Perceptions of Medications for Opioid Use Disorders from a Nationally Representative Survey in the United States. Subst Use Misuse, 58
(13), 1780-1788. https://doi.org/10.1080/10826084.2023.2247076.
Smith, L., Ingel, S.N., & Rudes, D.S. (2023). Like an animal: The well-being of women living in restricted housing units. Health & Justice,
11(1), 1-14.
Stein, L. A. R., Bassett, S. S., Welsh, W. N., Clair-Michaud, M., Abdel-Salam, S., Monico, L., Gallagher, C., Murgo, C., Yang, Y., Friedmann, P. D., Clarke, J. G., & Group, C.-D.-A. W. (2023). Implementation Strategy Fidelity and Organizational Outcomes in a Randomized Trial: Implications for Reentry from Corrections to Community Treatment. Subst Use Misuse, 58
(3), 320-330. https://doi.org/10.1080/10826084.2022.2161311.
Stoltman, J. J. K., Marra, A., Uppercue, K., & Terplan, M. (2023). Reporting on addiction: countering misinformation about addiction, harm reduction, treatment, and recovery. J Am Pharm Assoc (2003), 63
(1), 230-233. https://doi.org/10.1016/j.japh.2022.09.010.
Storholm, E. D., Huang, W., Ogunbajo, A., Horvath, K. J., Reback, C. J., Blumenthal, J., Moore, D. J., Flynn, R. P., Bolan, R. K., Corado, K. C., & Morris, S. R. (2023). Gender-Based Violence and Post-traumatic Stress Disorder Symptoms Predict HIV PrEP Uptake and Persistence Failure Among Transgender and Non-binary Persons Participating in a PrEP Demonstration Project in Southern California. AIDS Behav, 27
(2), 745-759. https://doi.org/10.1007/s10461-022-03807-1.
Sue, K. L., Chawarski, M., Curry, L., McNeil, R., Coupet, E., Jr., Schwartz, R. P., Wilder, C., Tsui, J. I., Hawk, K. F., D’Onofrio, G., O’Connor, P. G., Fiellin, D. A., & Edelman, E. J. (2023). Perspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department-Initiated Buprenorphine Programs. JAMA Netw Open, 6
(5), e2312718. https://doi.org/10.1001/jamanetworkopen.2023.12718.
Sufrin, C., Kramer, C., Terplan, M., Fiscella, K., Olson, S., Voegtline, K., & Latkin, C. (2023). Availability of Medications for Opioid Use Disorder in U.S. Jails. J Gen Intern Med, 38
(6), 1573-1575. https://doi.org/10.1007/s11606-022-07812-x.
Temkin, S. M., & Terplan, M. (2023). Levels of Gynecologic Care: A Task Force Consensus Statement. Obstet Gynecol, 142
(4), 993-994. https://doi.org/10.1097/AOG.0000000000005363.
Terplan, M. (2023). Asleep at the wheel: leadership in obstetrics and gynecology. Am J Obstet Gynecol.
https://doi.org/10.1016/j.ajog.2023.08.005.
Terplan, M. (2023). Urine Drug Screening for Isolated Marijuana Use in Labor and Delivery Units. Obstet Gynecol, 141
(3), 620. https://doi.org/10.1097/aog.0000000000005090.
Tofighi, B., Badiei, B., Badolato, R., Lewis, C. F., Nunes, E., Thomas, A., & Lee, J. D. (2023). Integrating Text Messaging in a Low Threshold Telebuprenorphine Program for New York City Residents with Opioid Use Disorder during COVID-19: A Pilot Randomized Controlled Trial. Journal of addiction medicine
, 17(5), e281–e286.
Tofighi, B., Lopez, R., Araujo, G., Lee, J.D., Samuels, E.A., Wightman, R.S., Butner, J. (2023). Provider and administrator attitudes and experiences with implementing telebuprenorphine during the COVID-19 pandemic: a mixed-methods survey. Journal of Substance Use
1-7.
Tofighi, B., Martino, D., Lekas, H.M., Williams, S.Z., Blau, C., Lewis, C.F. (2023). Scaling opioid overdose prevention and naloxone dispensation among rural and small metro area pharmacists: findings from a qualitative study. . Journal of Substance Use
28(4):568-73.
Ware, O. D., Sweeney, M. M., Cunningham, C., Umbricht, A., Stitzer, M., & Dunn, K. E. (2023). Bupropion Slow Release vs Placebo With Adaptive Incentives for Cocaine Use Disorder in Persons Receiving Methadone for Opioid Use Disorder: A Randomized Clinical Trial. JAMA Netw Open, 6
(3), e232278. https://doi.org/10.1001/jamanetworkopen.2023.2278.
West, B. S., Choi, S., & Terplan, M. (2023). In our responses to the overdose epidemic, we cannot forget pregnant and postpartum people. Int J Drug Policy, 120,
104153.
Wilde, J. A., Zawislak, K., Sawyer-Morris, G., Hulsey, J., Molfenter, T., & Taxman, F. S (2023). The adoption and sustainability of digital therapeutics in justice systems: A pilot feasibility study. Int J Drug Policy, 116,
104024. https://doi.org/10.1016/j.drugpo.2023.104024.
Work, E. C., Muftu, S., MacMillan, K. D. L., Gray, J. R., Bell, N., Terplan, M., Jones, H. E., Reddy, J., Wilens, T. E., Greenfield, S. F., Bernstein, J., & Schiff, D. M. (2023). Prescribed and Penalized: The Detrimental Impact of Mandated Reporting for Prenatal Utilization of Medication for Opioid Use Disorder. . Matern Child Health J,
1-9. https://doi.org/10.1007/s10995-023-03672-x.
Wu, L. T., John, W. S., Mannelli, P., Morse, E. D., Anderson, A., & Schwartz, R. P. ( (2023). Patient perspectives on community pharmacy administered and dispensing of methadone treatment for opioid use disorder: a qualitative study in the U.S. Addict Sci Clin Pract, 18
(1), 45. https://doi.org/10.1186/s13722-023-00399-6.
Wu, L. T., Mannelli, P., John, W. S., Anderson, A., & Schwartz, R. P (2023). Pharmacy-based methadone treatment in the US: views of pharmacists and opioid treatment program staff. Subst Abuse Treat Prev Policy,
18(1), 55. https://doi.org/10.1186/s13011-023-00563-w.
Xiong, X., Braun, S., Stitzer, M., Luderer, H., Shafai, G., Hare, B., Stevenson, M., & Maricich, Y. (2023). Evaluation of real-world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders. Am J Addict, 32
(1), 24-31. https://doi.org/10.1111/ajad.13346.
Zarkin, G. A., Orme, S., Dunlap, L. J., Kelly, S. M., Mitchell, S. G., O’Grady, K. E., & Schwartz, R. P. (2023). Corrigendum to “Cost and cost-effectiveness of interim methadone treatment and patient navigation initiated in jail” [Drug Alcohol Depend. 217 (2020) 108292]. Drug Alcohol Depend,
110913. https://doi.org/10.1016/j.drugalcdep.2023.110913.
Zaugg, C., Terplan, M., & Roberts, S. C. M. (2023). Clinician views on reporting pregnant and birthing patients who use alcohol and/or drugs to child welfare. Am J Obstet Gynecol MFM,
5(10), 101109. https://doi.org/10.1016/j.ajogmf.2023.101109.
Zhou, X., Thompson, L. K., Pagano, A., Rahman, N., Patel, S., Gibson, D., Ibrahim, A., Casanova, B., Schwartz, R. P., Vocci, F. J., & Clarke, D. E. (2023). Patient Engagement in and Adaptations to Delivery of Outpatient Care for Opioid Use Disorder During the COVID-19 Pandemic. Psychiatr Serv,
appips202100507. https://doi.org/10.1176/appi.ps.202100507.
2022
Agabio, R., Sinclair, J., Terplan, M., Traccis, F., & Minozzi, S. (2022). Psychosocial and medication interventions to stop or reduce alcohol consumption during pregnancy. The Cochrane Database of Systematic Reviews, 4.
https://doi.org/https://doi.org/10.1002/14651858.CD015042.
Alexander K., & Clary-Muronda, V. (2022). A scoping review of interventions seeking to improve aspects of patient-provider relationships involving Black pregnant and post-partum people. Journal of Advanced Nursing,
00, 1– 11. https://doi.org/10.1111/jan.15537.
Alexander, K., & Clary-Muronda, V. (2022). A scoping review of interventions seeking to improve aspects of patient-provider relationships involving Black pregnant and post-partum people. Journal of Advanced Nursing
1-11. Doi: 10.1111/jan.15537.
Alexander, K., Smith, J. M., Gerolamo, A., & Bernhardt, J. (2022). The impact of nursing on health outcomes of people receiving medication for opioid use disorder: An integrative review. Journal of Nursing Scholarship
, 1-9. Doi: 10.1111/jnu.12858.
Barbosa, C., Cowell, A., Dunlap, L., Wedehase, B., Dušek, K., Schwartz, R. P., Gryczynski, J., Barnosky, A., Kirk, A. S., Oros, M., Hosler-Moore, C., O’Grady, K. E., Brown, B. S., & Mitchell, S. G. (2022). Costs and implementation effectiveness of generalist versus specialist models for adolescent screening and brief intervention in primary care. Journal of Studies on Alcohol and Drugs, 83
(2), 231-238. Doi: 10.15288/jsad.2022.83.231.
Baskerville, W. A., Friedman, T. C., Hurley, B., Hsieh, S., Dixon, T., Mtume, N., Lee, M. L., Rodriguez, L., Lopez, B., & Ray, L. A. (2022). Embedding comprehensive smoking cessation programs into community clinics: study protocol for a cluster-randomized controlled trial. Trials, 23
(1), 109. doi: 10.1186/s13063-022-06023-3.
Bo, A., Goings, T. C., Evans, C. B., Sharma A., Jennings, Z., Durand, B., Bardeen, A., & Murray-Lichtman, A. (2022). Culturally sensitive prevention programs for substance use among adolescents of color: A systematic review and meta-analysis of randomized controlled trials. Clinical Psychology Review
, 102233.
Brenneke, S. G., Nordeck, C. D., Riehm, K. E., Schmid, I., Tormohlen, K. N., Smail, E. J., Johnson, R. M., Kalb, L. G., Stuart, E. A., & Thrul, J. (2022). Trends in cannabis use among U.S. adults amid the COVID-19 pandemic. The International Journal on Drug Policy, 100, 103517.
Doi: 10.1016/j.drugpo.2021.103517.
Brooner, R. K., Stoller, K. B., Patel, P., Wu, L. T., Yan, H., & Kidorf, M (2022). Opioid treatment program prescribing of methadone with community pharmacy dispensing: Pilot study of feasibility and acceptability. Drug and Alcohol Dependence Reports, 3.
Doi: 10.1016/j.dadr.2022.100067.
Bunting, A.M., Krawczyk, N., Choo, T.W., Pavlicova, M., McNeely, J., Tofighi, B., Rotrosen, J., Nunes, E., Lee, J.D. (2022). Polysubstance use before and during treatment with medication for opioid use disorder: Prevalence and association with treatment outcomes. J Subst Abuse Treat,
143, 108830.
Carswell, S.B., Gordon MS, Gryczynski J, Taxman FS, Schadegg M, Ferguson KN & Maher K (2022). Continuing care application for probationers and parolees with substance use disorders. Journal of Drug Education, 51
(1-2), 32-48, DOI 10.1177/00472379221111.
Cheng, A., Badolato, R., Segoshi, A., McDonald, R., Malone, M., Vasudevan, K., Badiei, B., Sugarman, A., Macdonald, R., Mangat, J., Giftos, J., Tofighi, B. (2022). Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: an in-depth qualitative study. Addiction Science & Clinical Practice
17(1):1-9.
Darlington, C., Teitelman, A., Compton, P., Alexander K. (2022). Depression and anxiety interventions among pregnant and parenting women with substance use disorders: A systematic review. Drug and Alcohol Dependence Reports.
Espinoza-Derout, J., Shao, X. M., Lao, C. J., Hasan, K. M., Rivera, J. C., Jordan, M. C., Echeverria, V., Roos, K. P., Sinha-Hikim, A. P., & Friedman, T. C. (2022). Electronic Cigarette Use and the Risk of Cardiovascular Diseases Frontiers in Cardiovascular Medicine, 9.
, 879726. doi: 10.3389/fcvm.2022.879726.
Fletcher, J. B., & Reback, C. J. (2022a). Associations between gender identity control, gender identity non-verification, and health risks among trans women of color living with HIV. Archives of Sexual Behavior, 51
(4), 2003-2014. Doi: 10.1007/s10508-021-02264-6.
Fletcher, J. B., & Reback, C. J. (2022b). Optimizing outpatient treatment outcomes among methamphetamine-using gay and bisexual men through a computerized depression intervention. Journal of Substance Abuse Treatment, 136
, 108663. Doi: 10.1016/j.jsat.2021.108663.
Giang, L. M., Trang, N. T., Diep, N. B., Thuy, D. T. D., Thuy, D. T., Hoe, H. D., Van, H. T. H., Truc, T. T., Nguyen, H. H., Lai, N. L., Linh, P. T. D., Vi, V. T. T., Reback, C. J., Leibowitz, A., Li, L., Lin, C., Li, M., Do Van, D., & Shoptaw, S. (2022). An adaptive design to Screen, Treat, And Retain people with opioid use disorders who use methamphetamine in methadone clinics (STAR-OM): Study protocol of a clinical trial. Trials, 23
(1), 342. Doi: 10.1186/s13063-022-06278-w.
Glasner, S., Patrick, K., Ybarra, M., Reback, C. J., Ang, A., Kalichman, S., Bachrach, K., Garneau, H. C., Venegas, A., & Rawson, R. A. (2022). Promising outcomes from a cognitive behavioral therapy text-messaging intervention targeting drug use, antiretroviral therapy adherence, and HIV risk behaviors among adults living with HIV and substance use disorders. Drug and Alcohol Dependence Reports, 231
, 109229. Doi: 10.1016/j.drugalcdep.2021.109229.
Glasner, S., Webb, J., Michero, D., Motschman, C., Monico, L., Ang, A., & Pielsticker, P. (2022). Feasibility, acceptability, and preliminary outcomes of an integrated telemedicine intervention combining naltrexone and cognitive behavioral therapy for alcohol use disorder. Telemedicine Reports, 3
(1), 184-190. Doi: 10.1089/tmr.2022.0029.
Gryczynski J, Sanchez K, Carswell, S.B. & Schwartz RP (2022). Development, feasibility, and preliminary validation of a Spanish language version of the TAPS Tool for substance use screening in primary care. Addiction Science & Clinical Practice,
17(S1), 33.
Henningfield, J. E., Coe, M. A., Griffiths, R. R., Belouin, S. J., Berger, A., Coker, A. R., Comer, S. D., Heal, D. J., Hendricks, P. S., Nichols, C. D., Sapienza, F., Vocci, F. J., & Zia, F. Z. (2022). Psychedelic drug abuse potential assessment research for new drug applications and controlled substances act scheduling. Neuropharmacology, 218
, 109220. Doi: 10.1016/j.neuropharm.2022.109220.
Hochstatter, K. R., Rastogi, S., Klein, K., Tait-Ozer, C., El-Bassel, N., & Graham, J. (2022). Predicting accidental drug overdose as the cause of fatality in near real-time using the Suspected Potential Overdose Tracker (SPOT): Public health implications. BMC Public Health, 22
(1), 1311. Doi: 10.1186/s12889-022-13700-0.
Hochstatter, K. R., Slavin, M. N., Gilbert, L., Goddard-Eckrich, D., & El-Bassel, N. (2022). Availability of informal social support and the impact on health services utilization among women in community corrections who engage in substance use and risky sexual behavior: New York City, 2009-2012. Health Justice, 10
(1), 6. Doi: 10.1186/s40352-022-00170-0.
Hochstatter, K. R., Terplan, M., Mitchell, S. G., Schwartz, R. P., Dusek, K., Wireman, K., & Gryczynski, J. (2022). Characteristics and correlates of fentanyl preferences among people with opioid use disorder. Drug and Alcohol Dependence, 240
, 109630. Doi: 10.1016/j.drugalcdep.2022.109630.
Ingel, S.N., Barberi, D., Rudes, D.S., & Taxman, F.S (2022). Lessons Learned from a Peer Support Program for Individuals Seeking Substance Use Recovery. Journal of Offender Rehabilitation,
61(8), 411-425.
Ingel, S.N., Davis, L. Drazdowski, T.K., Rudes, D.S., *Hartwell, T. N., McCart, M.R., Chapman, J.E., Taxman, F.S., & Sheidow, A. J. (2022). The Role of Families in Juvenile Probation: Juvenile Probation Officers Perceptions of Parental Involvement. Criminal Justice & Behavior, 50(1).
Ingel, S.N., Davis, L. Drazdowski, T.K., Rudes, D.S., Hartwell, T. N., McCart, M.R., Chapman, J.E., Taxman, F.S., & Sheidow, A. J (2022). Juvenile Probation Officers’ Perceptions of Sanctions and Incentives as Compliance Strategies. Journal of Applied Juvenile Justice Services,
27.
Jilani, S. M., Jones, H. E., Grossman, M., Jansson, L. M., Terplan, M., Faherty, L. J., Khodyakov, D., Patrick, S. W., & Davis, J. M. (2022). Standardizing the clinical definition of opioid withdrawal in the neonate. Journal of Pediatrics, 243
, 33-39.e31. Doi: 10.1016/j.jpeds.2021.12.021.
Jilani, S. M., Jones, H. E., Jansson, L. M., Terplan, M., & Davis, J. M. (2022). Reply. Journal of Pediatrics, 246
, 283-284. Doi: 10.1016/j.jpeds.2022.04.022.
Karnik, N. S., Marsden, J., McCluskey, C., Boley, R. A., Bradley, K. A., Campbell, C. I., Curtis, M. E., Fiellin, D., Ghitza, U., Hefner, K., Hser, Y. I., McHugh, R. K., McPherson, S. M., Mooney, L. J., Moran, L. M., Murphy, S. M., Schwartz, R. P., Shmueli-Blumberg, D., Shulman, M., Stephens, K. A., Watkins, K. E., Weiss, R. D., & Wu, L. T. (2022). The Opioid Use Disorder Core Outcomes Set (OUD-COS) for treatment research: Findings from a Delphi consensus study. Addiction, 117
(9), 2438-2447. Doi: 10.1111/add.15875.
Karpyn, A., Pon, J., Grajeda, S. B., Wang, R., Merritt, K. E., Tracy, T., May, H., Sawyer-Morris, G., Halverson, M. M., & Hunt, A. (2022). Understanding Impacts of SNAP Fruit and Vegetable Incentive Program at Farmers’ Markets: Findings from a 13 State RCT. Int J Environ Res Public Health, 19
(12). https://doi.org/10.3390/ijerph19127443.
Kelty, E., Terplan, M., Orr, C., & Preen, D. B. (2022). Neonatal outcomes associated with in utero exposure to oxycodone, overall and by trimester of exposure: A retrospective cohort study. The Journal of Pain.
Doi: 10.1016/j.jpain.2022.11.007.
Kim, S. C., & Friedman, T. C. (2022). A New Ingenious Enemy: Heat-Not-Burn Products. Tobacco Use Insights, 15,
1179173x221076419. doi: 10.1177/1179173x221076419.
Kisler, K. A., Fletcher, J. B., & Reback, C. J. (2022). Peer case management promoting advancement along the HIV care continuum among black men who have sex with men living with HIV: Building Brothers Up. AIDS Patient Care and STDs, 36
(S1), S46-s53. Doi: 10.1089/apc.2022.0105.
Koenigs, K. J., Chou, J. H., Cohen, S., Nolan, M., Liu, G., Terplan, M., Cummings, B. M., Nielsen, T., Smith, N. A., Distefano, J., Bernstein, S. N., & Schiff, D. M. (2022). Informed consent is poorly documented when obtaining toxicology testing at delivery in a Massachusetts cohort. American Journal of Obstetrics & Gynecology MFM, 4
(4), 100621. Doi: 10.1016/j.ajogmf.2022.100621.
Kras, K. R., Meyer, K. S., Dmello, J. R., & Rudes, D. S. (2022). Individual and Organizational Correlates of Morale Among Workers in a Youth and Family Court Agency. Crime & Delinquency. (online first)
Lewis, C.F., Williams, S.Z., Tofighi, B., Lekas, H.M., Joseph, A., Rivera, A., Amesty, S.C (2022). Internet use and uptake of a web-based prevention and risk reduction intervention for persons who use drugs in New York City–WebHealth4Us study (2013–2016). Substance Abuse
43(1):1119-26.
Lim, G., Soens, M., Wanaselja, A., Chyan, A., Carvalho, B., Landau, R., George, R. B., Klem, M. L., Osmundson, S. S., Krans, E. E., Terplan, M., & Bateman, B. T. (2022). A systematic scoping review of peridelivery pain management for pregnant people with opioid use disorder: From the Society for Obstetric Anesthesia and Perinatology and Society for Maternal Fetal Medicine. Anesthesia and Analgesia, 135
(5), 912-925. Doi: 10.1213/ane.0000000000006167.
Ludwig, A., Monico, L. B., Blue, T., Gordon, M. S., Schwartz, R. P., & Mitchell, S. G. (2022). Development and use of a checklist for the implementation of medication for opioid use disorder in jails. Implementation Research and Practice, 3
, 26334895221101214. Doi: 10.1177/26334895221101214.
Lyons, M. S., Chawarski, M. C., Rothman, R., Whiteside, L., Cowan, E., Richardson, L. D., Hawk, K., Tsui, J. I., Schwartz, R. P., O’Connor, P., D’Onofrio, G., Fiellin, D. A., & Edelman, E. J. (2022). Missed opportunities for HIV and Hepatitis C screening among emergency department patients with untreated opioid use disorder. Journal of Addiction Medicine.
Doi: 10.1097/adm.0000000000001074.
Marques, P. X., Wand, H., Nandy, M., Tan, C., Shou, H., Terplan, M., Mark, K., Brotman, R. M., Wilson, D. P., Ravel, J., Hsia, R. C., & Bavoil, P. M. (2022). Serum antibodies to surface proteins of Chlamydia trachomatis as candidate biomarkers of disease: results from the Baltimore Chlamydia Adolescent/Young Adult Reproductive Management (CHARM) cohort. FEMS microbes,
3. https://doi.org/https://doi.org/10.1093/femsmc/xtac004.
Martin, C. E., Parlier-Ahmad, A. B., Beck, L., Jain, V., & Terplan, M. (2022). A comparison of sex-specific reproductive and sexual health needs between addiction medicine and primary care treatment settings. Substance Use and Misuse, 57
(8), 1229-1236. Doi: 10.1080/10826084.2022.2076873.
Martin, C. E., Parlier-Ahmad, A. B., Beck, L., Scialli, A., & Terplan, M. (2022). Need for and receipt of substance use disorder treatment among adults, by gender, in the United States. Public Health Reports, 137
(5), 955-963. Doi: 10.1177/00333549211041554.
Mitchell, M., Hansen, E., Tseng, T. Y., Shen, M., Catanzarite, Z., Cruz-Oliver, D., Parker, L., & Knowlton, A. (2022). Caregiver role strain in caring for vulnerable persons living with HIV: Correlates of caregiver and care recipient reports. AIDS Care, 34
(10), 1314-1320. Doi: 10.1080/09540121.2021.1968997.
Mitchell, S. G., Monico, L. B., Gryczynski, J., Ross, T., Terplan, M., & O’Grady, K. E. (2022). Examining the Effectiveness of the FaCES Adolescent SBIRT Intervention. J Adolesc Health, 71
(4s), S41-s48. https://doi.org/10.1016/j.jadohealth.2022.04.013.
Mitchell, S. G., Nordeck, C. D., Lertch, E., Ross, T. E., Welsh, C., Schwartz, R. P., & Gryczynski, J. (2022). Patients with substance use disorders receiving continued care in skilled nursing facilities following hospitalization. Substance Abuse, 43
(1), 848-854. Doi: 10.1080/08897077.2021.2007512.
Mitchell, S. G., Truitt, A. R., Davin, L. M., & Rindal, D. B. (2022). Pain management after third molar extractions in adolescents: A qualitative study. BMC Pediatrics, 22
(1), 184. Doi: 10.1186/s12887-022-03261-x.
Molina, M. F., Hall, S. M., Stitzer, M., Kushel, M., Chakravarty, D., & Vijayaraghavan, M. (2022). Contingency management to promote smoking cessation in people experiencing homelessness: Leveraging the electronic health record in a pilot, pragmatic randomized controlled trial. PLoS One, 17
(12), e0278870. Doi: 10.1371/journal.pone.0278870.
Monico, L. B., Ludwig, A., Lertch, E., Schwartz, R. P., Fishman, M., & Mitchell, S. G. (2022). Post-residential treatment outpatient care preferences: Perspectives of youth with opioid use disorder. Journal of Substance Abuse Treatment, 137
, 108692.Doi: 10.1016/j.jsat.2021.108692.
Mun, C. J., Nordeck, C., Goodell, E. M. A., Vandrey, R., Zipunnikov, V., Dunn, K. E., Finan, P. H., & Thrul, J. (2022). Real-time monitoring of cannabis and prescription opioid co-use patterns, analgesic effectiveness, and the opioid-sparing effect of cannabis in individuals with chronic pain. The Journal of Pain, 23
(11), 1799-1810. doi: 10.1016/j.jpain.2022.06.009.
Nidey, N., Hoyt-Austin, A., Chen, M. J., Bentley, B., Tabb, K. M., Anyigbo, C., Wilder, C., Terplan, M., McAllister, J. M., Wexelblatt, S. L., Murnan, A., & Kair, L. R. (2022). Racial inequities in breastfeeding counseling among pregnant people who use cannabis. Obstetrics and Gynecology, 140
(5), 878-881. Doi: 10.1097/aog.0000000000004834.
Nordeck, C., Gryczynski, J., Schwartz, R. P., Mitchell, S. G., Welsh, C., & O’Grady, K. E. (2022). Opioid agonist treatment initiation and linkage for hospitalized patients seen by a substance use disorder consultation service. Drug and Alcohol Dependence Reports,
(2), 100031.
Orme, S., Zarkin, G. A., Dunlap, L. J., Nordeck, C. D., Schwartz, R. P., Mitchell, S. G., Welsh, C., O’Grady, K. E., & Gryczynski, J. (2022). Cost and cost savings of navigation services to avoid rehospitalization for a comorbid substance use disorder population. Medical Care, 60
(8), 631-635. Doi: 10.1097/mlr.0000000000001743.
Petrucci, C., & Rivera-Figueroa, A. (2022). STEM faculty mentoring and advising at an urban Hispanic-service community college. Community College Journal of Research and Practice.
Doi: 10.1080/10668926.2022.2056549.
Rose, J. E., Behm, F. M., Botts, T. L., Botts, D. R., Willette, P. N., Vocci, F., & McCarty, J. (2022). Novel rapid-acting sublingual nicotine tablet as a cigarette substitution strategy. Psychopharmacology, 239
(9), 2853-2862. Doi: 10.1007/s00213-022-06171-z.
Rudes, D.S. with Magnuson, S. & Hattery, A. (2022). Surviving Solitary: Living and Working Within Restricted Housing Units.
Stanford University Press.
Samuels, E.A., Khatri, U.G., Snyder, H., Wightman, R.S., Tofighi, B., Krawczyk, N. (2022). Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19. Journal of general internal medicine
1-3.
Saunders, E. C., Satcher, M. F., Monico, L. B., McDonald, R. D., Springer, S. A., Farabee, D., Gryczynski, J., Nyaku, A., Reeves, D., Kunkel, L. E., Schultheis, A. M., Schwartz, R. P., Lee, J. D., Marsch, L. A., & Waddell, E. N. (2022). The impact of COVID-19 on the treatment of opioid use disorder in carceral facilities: A cross-sectional study Health Justice, 10
(1), 35. Doi: 10.1186/s40352-022-00199-1.
Schiff, D. M., Stoltman, J. J. K., Nielsen, T. C., Myers, S., Nolan, M., Terplan, M., Patrick, S. W., Wilens, T. E., & Kelly, J. (2022). Assessing stigma towards substance use in pregnancy: A randomized study testing the impact of stigmatizing language and type of opioid use on attitudes toward mothers with opioid use disorder. Journal of Addiction Medicine, 16
(1), 77-83. Doi: 10.1097/adm.0000000000000832.
Schiff, D. M., Work, E. C., Muftu, S., Partridge, S., MacMillan, K. D. L., Gray, J. R., Hoeppner, B. B., Kelly, J. F., Greenfield, S. F., Jones, H. E., Wilens, T. E., Terplan, M., & Bernstein, J. (2022). “You have to take this medication, but then you get punished for taking it:” Lack of agency, choice, and fear of medications to treat opioid use disorder across the perinatal period. Journal of Substance Abuse Treatment, 139
, 108765. Doi: 10.1016/j.jsat.2022.108765.
Sevelius, J. M., Dilworth, S. E., Reback, C. J., Chakravarty, D., Castro, D., Johnson, M. O., McCree, B., Jackson, A., Mata, R. P., & Neilands, T. B. (2022). Randomized controlled trial of healthy divas: A gender-affirming, peer-delivered intervention to improve HIV care engagement among transgender women living with HIV. Journal of Acquired Immune Deficiency Syndromes, 90
(5), 508-516. Doi: 10.1097/qai.0000000000003014.
Sharma A., Mitchell, S.G., Nordeck, C.D., Schwartz, R.P., Dusek, K., O’Grady, K., Gryczynski, J. (2022). Sexually Transmitted Infection (STI) testing after brief intervention for risk behaviors in school-based health centers (SBHCs) Journal of Adolescent Health, 70
(4), 577-583.
Sharma, A., Mitchell, S. G., Nordeck, C. D., Schwartz, R. P., Dusek, K., O’Grady, K. E., & Gryczynski, J. (2022). Sexually Transmitted Infection testing after brief intervention for risk behaviors in school-based health centers (SBHCs). Journal of Adolescent Health,
70(4), 577-583, doi: 10.1016/j.jadohealth.2021.11.013.
Smid, M. C., & Terplan, M. (2022). What obstetrician-gynecologists should know about substance use disorders in the perinatal period. Obstetrics and Gynecology, 139
(2), 317-337. Doi: 10.1097/aog.0000000000004657.
Stoltman, J. J. K., Lander, L. R., Patrick, J. H., Terplan, M., & Jones, H. E. (2022). Interest in co-located reproductive and sexual health services among women and men receiving medication for opioid use disorder in an outpatient treatment clinic. Front Psychiatry, 13
, 910389. Doi: 10.3389/fpsyt.2022.910389.
Stoltman, J. J. K., Marra, A., Uppercue, K., & Terplan, M. ( (2022). Reporting on Addiction: An Innovative, Collaborative Approach to Reduce Stigma by Improving Media Coverage and Public Messaging about Addiction Treatment and Recovery. Drug and Alcohol Dependence, 241
, 109648. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2022.109648.
Storholm, E. D., Huang, W., Ogunbajo, A., Horvath, K. J., Reback, C. J., Blumenthal, J., Moore, D. J., Flynn, R. P., Bolan, R. K., Corado, K. C., & Morris, S. R. (2022). Gender-based violence and post-traumatic stress disorder symptoms predict HIV PrEP uptake and persistence failure among transgender and non-binary persons participating in a PrEP demonstration project in Southern California. AIDS and Behavior.
Doi: 10.1007/s10461-022-03807-1.
Storholm, E. D., Ogunbajo, A., Nacht, C. L., Opalo, C., Horvath, K. J., Lyman, P., Flynn, R., Reback, C. J., Blumenthal, J., Moore, D. J., Bolan, R., & Morris, S. (2022). Facilitators of PrEP persistence among black and latinx transgender women in a PrEP demonstration project in Southern California. Behavior Medicine,
1-12. Doi: 10.1080/08964289.2022.2105794.
Suarez, E. A., Huybrechts, K. F., Straub, L., Hernández-Díaz, S., Jones, H. E., Connery, H. S., Davis, J. M., Gray, K. J., Lester, B., Terplan, M., Mogun, H., & Bateman, B. T. (2022). Buprenorphine versus methadone for opioid use disorder in pregnancy. The New England Journal of Medicine, 387
(22), 2033-2044. Doi: 10.1056/NEJMoa2203318.
Sufrin, C., Kramer, C. T., Terplan, M., Fiscella, K., Olson, S., Voegtline, K., & Latkin, C. (2022b). Availability of medications for the treatment of opioid use disorder among pregnant and postpartum individuals in US Jails. JAMA Network Open, 5
(1), e2144369. doi: 10.1001/jamanetworkopen.2021.44369.
Sufrin, C., Kramer, C., Terplan, M., Fiscella, K., Olson, S., Voegtline, K., & Latkin, C. (2022a). Availability of medications for opioid use disorder in US Jails. Journal of General Internal Medicine.
Doi: 10.1007/s11606-022-07812-x.
Sugarman, A., Vittitow, A., Cheng, A., Malone, M., McDonald, R., Pace, N., Williams, O., Tofighi, B., McNeely, J., Schatz, D., Roberts, T. (2022). Opioid Use Disorder Treatments: An Evidence Map. Drug and Alcohol Dependence
241:109657.
Sweeney, M. M., Holtyn, A. F., Stitzer, M. L., & Gastfriend, D. R. (2022). Practical technology for expanding and improving substance use disorder treatment: Telehealth, remote monitoring, and digital health interventions. The Psychiatric Clinics of North America, 45
(3), 515-528. doi: 10.1016/j.psc.2022.05.006.
Terplan, M. (2022a). Prenatal nicotine or cannabis exposure and offspring neurobehavioral outcomes. Obstetrics and Gynecology, 139
(5), 939. doi: 10.1097/aog.0000000000004779.
Terplan, M. (2022b). Test or talk: Empiric bias and epistemic injustice. Obstetrics and Gynecology, 140
(2), 150-152. doi: 10.1097/aog.0000000000004884.
Thompson, H. M., Clement, A. M., Ortiz, R., Preston, T. M., Quantrell, A. L. W., Enfield, M., King, A. J., Klosinski, L., Reback, C. J., Hamilton, A., & Milburn, N. (2022). Community engagement to improve access to healthcare: A comparative case study to advance implementation science for transgender health equity. International Journal for Equity in Health, 21
(1), 104. doi: https://doi.org/10.1186/s12939-022-01702-8.
Tofighi, B., Durr, M., Marini, C., Lewis, C.F., Lee, J.D. (2022). A Mixed-Methods Evaluation of the Feasibility of a Medical Management-Based Text Messaging Intervention Combined With Buprenorphine in Primary Care. Substance Abuse: Research and Treatment
16:11.
Tofighi, B., McNeely, J., Yang, J., Thomas, A., Schatz, D., Reed, T., Krawczyk, N. (2022). Outcomes of a NYC Public Hospital System Low-Threshold Tele-Buprenorphine Bridge Clinic at 1 Year. Substance Use & Misuse
DOI: 10.1080/10826084.2022.2069269.
Winstanley, E.L., Thacker, E.P., Choo, L.Y., Lander, L.R., Berry, J.H, Tofighi, B. (2022). Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use. Drug and Alcohol Dependence Reports
5:100091.
Woodhams, E., Samura, T., White, K., Patton, E., & Terplan, M (2022). Society of family planning clinical recommendations: Contraception and abortion care for persons who use substances. Contraception, 112
, 2-10. doi: 10.1016/j.contraception.2022.05.010.
Wu, L. T., John, W. S., Morse, E. D., Adkins, S., Pippin, J., Brooner, R. K., & Schwartz, R. P (2022). Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: Results from a feasibility clinical trial. Addiction, 117
(2), 444-456. doi: 10.1111/add.15641.
Wunderlich, J.R., Engelberg, R.S., Tofighi, B., Schwartz, M.D. (2022). Time for Pharmacy Co-dispensing of Naloxone with Prescribed Opioids? Journal of General Internal Medicine
1-3.
Young-Wolff, K. C., Slama, N. E., Sarovar, V., Terplan, M., Ansley, D., Adams, S. R., & Alexeeff, S. E. (2022). Trends in self-reported and biochemically verified cocaine and methamphetamine use among pregnant individuals in Northern California, 2011-2019. JAMA Network Open, 5
(12), e2248055. doi: 10.1001/jamanetworkopen.2022.48055.
Young-Wolff, K. C., Slama, N., Sarovar, V., Conway, A., Tucker, L. Y., Goler, N., Terplan, M., Ansley, D., Adams, S. R., & Armstrong, M. A. (2022). Association of pregnancy intentions with substance use during early pregnancy. Journal of Addiction Medicine, 16
(1), 118-121. doi: 10.1097/adm.0000000000000825.
Zaller, N. D., Gorvine, M. M., Ross, J., Mitchell, S. G., Taxman, F. S., & Farabee, D. (2022). Providing substance use disorder treatment in correctional settings: Knowledge gaps and proposed research priorities-overview and commentary. Addiction Science & Clinical Practice, 17
(1), 69. doi: 10.1186/s13722-022-00351-0.
2021
Admon, L. K., Terplan, M., & Winkelman, T. N. A. (2021). A closer look at health Inequities among pregnant people with unstable housing. JAMA Network Open, 4
(4), e217855.
Bachireddy, C., & Terplan, M. (2021). Payer strategies to ensure access to care for individuals with opioid use disorder during COVID-19. American Journal of Managed Care, 27
(3), 91-92.
Bagley, S. M., Chavez, L., Braciszewski, J. M., Akolsile, M., Boudreau, D. M., Lapham, G., Campbell, C. I., Bart, G., Yarborough, B. J. H., Samet, J. H., Saxon, A. J., Rossom, R. C., Binswanger, I. A., Murphy, M. T., Glass, J. E., Bradley, K. A., & PROUD Collaborative (Szapocznik, J., Liebschutz, J. M., Ahmedani, B. K., Pflugeisen, B. M., Schwartz, R. P., Stotts, A. L., Northrup, T. F., Horigian, V. E., Silva, A.J.). (2021). Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems. . Addiction Science & Clinical Practice, 16
(1), 46.
Blair, C. S., Holloway, I. W., Fletcher, J. B., & Reback, C. J. (2021). Network characteristics associated with HIV testing conversations among transgender women in Los Angeles County, California. AIDS & Behavior, 25
(8), 2336-2347.
Borda, J.P., Friedman, H., Buitrago, J., Isaza, M., Herrera, P., Krawczyk, N., Tofighi, B. (2021). Barriers to treatment for opioid use disorder in Colombia. Journal of Substance Use
pp.1-7.
Borda, J.P., Friedman, H.L., Castaño, G.A., Rodríguez, H.A., Muñoz, C.F., Tofighi, B. (2021). Barriers to HIV and Hepatitis C care for people who inject drugs in Colombia. AIDS Care
1-6.
Campbell, C. I., Saxon, A. J., Boudreau, D. M., Wartko, P. D., Bobb, J. F., Lee, A. K., Matthews, A. G., McCormack, J., Liu, D. S., Addis, M., Altschuler, A., Samet, J. H., LaBelle, C. T., Arnsten, J., Caldeiro, R. M., Borst, D. T., Stotts, A. L., Braciszewski, J. M., Szapocznik, J., Bart, G., Schwartz, R. P., McNeely, J., Liebschutz, J. M., Tsui, J. I., Merrill, J. O., Glass, J. E., Lapham, G. T., Murphy, S. M., Weinstein, Z. M., Yarborough, B. H., & Bradley, K. A. (2021). PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: A pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment. Addiction Science & Clinical Practice, 16
(1), 9.
Clarke, D. E., Ibrahim, A., Doty, B., Patel, S., Gibson, D., Pagano, A., Thompson, L., Goldstein, A. B., Vocci, F., & Schwartz, R. P. (2021). Addiction Medicine Practice-based Research Network (AMNet): Assessment tools and quality measures. Substance Abuse & Rehabilitation, 12,
27-39.
Crable, E. L., Blue, T. R., McKenzie, M., Rich, J. D., & Gordon, M. S. (2021). Effect of case management on HIV outcomes for community corrections population: Results of an 18-month randomized controlled trial. JAIDS Journal of Acquired Immune Deficiency Syndromes, 87
(1), 755-762.
El-Shahawy, O., Schatz, D., Sherman, S., Shelley, D., Lee, J.D., Tofighi, B. (2021). E-cigarette use and beliefs among adult smokers with substance use disorders. Addictive Behaviors Reports
13.
Falade-Nwulia, O., Momoh, O., Felsher, M., Nwulia, E., Tofighi, B., Ward, K., McCormick, S., Sulkowski, M., Latkin, C. (2021). Validation of a tool to assess effectiveness of peer-recruitment for hepatitis C testing and linkage to care among people who inject drugs. Drug & alcohol dependence
230:109177.
Fehrenbacher, A. E., Fletcher, J. B., Clark, K. A., Kisler, K. A., & Reback, C. J. (2021). Social networks and exchange sex among transgender women. Journal of Sex Research, 58
(6), 743-753.
Flavin, L., Tofighi, B., Krawczyk, N., Schatz, D., McNeely, J., Butner, J (2021). Low Threshold Telemedicine-based Opioid Treatment for Criminal Justice Involved Adults During the COVID-19 Pandemic: A Case Report. Journal of Addiction Medicine.
Fletcher, J. B., & Reback, C. J. (2021). Optimizing outpatient treatment outcomes among methamphetamine-using gay and bisexual men through a computerized depression intervention. Journal of Substance Abuse & Treatment,
108663.
Fletcher, J. B., Clark, K. A., & Reback, C. J (2021). Depression and HIV transmission risk among methamphetamine-Using men who have sex with men. Addiction Research & Theory, 29
(3), 263-270.
Foudray, M., Kramer, C., Rudes, D.S., Suffrin, C., Burr, E., & Parayil, T. (2021). The Compendium of U.S. Jails: Creating and Conducting Research with the First Comprehensive Contact Database of U.S. Jails. Health & Justice,
19(1), 1-13.
Giovenco, D., Muessig, K. E., Horvitz, C., Biello, K. B., Liu, A. Y., Horvath, K. J., Golinkoff, J. M., Reback, C. J., & Hightow-Weidman, L. (2021). Adapting technology-based HIV prevention and care interventions for youth: Lessons learned across five U.S. Adolescent Trials Network studies. mHealth, 7,
21.
Glasner, S., Patrick, K., Ybarra, M., Reback, C. J., Ang, A., Kalichman, S., Bachrach, K., Garneau, H. C., Venegas, A., & Rawson, R. A. (2021). Promising outcomes from a cognitive behavioral therapy text-messaging intervention targeting drug use, antiretroviral therapy adherence, and HIV risk behaviors among adults living with HIV and substance use disorders. Drug & Alcohol Dependence, 231,
109229.
Gordon, M. S., Mitchell, S. G., Blue, T. R., Vocci, F. J., Fishman, M. J., Murphy, S. M., Couvillion, K., Maher, K., Ryan, D., Wenzel, K., Danner, M. L., & Jarvis, D. K. (2021). A clinical protocol of a comparative effectiveness trial of extended-release naltrexone versus extended-release buprenorphine with individuals leaving jail. Journal of Substance Abuse Treatment, 128,
108241.
Gryczynski, J., Lee, J. D., Dusek, K., McDonald, R., Sharma A., Malone, M., … & Chilcoat, H. D. (2021). Use of non–prescribed buprenorphine in the criminal justice system: Perspectives of individuals recently released from incarceration. Journal of Substance Abuse Treatment, 127
, 108349.
Gryczynski, J., Lee, J. D., Dusek, K., McDonald, R., Sharma, A., Malone, M., Monico, L. B., Cheng, A., DeVeaugh-Geiss, A., & Chilcoat, H. D. (2021). Use of non-prescribed buprenorphine in the criminal justice system: Perspectives of individuals recently released from incarceration. Journal of Substance Abuse Treatment, 127,
108349.
Gryczynski, J., Mitchell, S. G., Schwartz, R. P., Dusek, K., O’Grady, K. E., Cowell, A. J., Barbosa, C., Barnosky, A., & DiClemente, C. C. (2021). Computer- vs. nurse practitioner-delivered brief intervention for adolescent marijuana, alcohol, and sex risk behaviors in school-based health centers Drug & Alcohol Dependence,
218, 108423.
Gryczynski, J., Nordeck, C. D., Welsh, C., Schwartz, R. P., Mitchell, S. G., & O’Grady, K. E. (2021). Preventing Hospital Readmission for Patients with Comorbid Substance Use Disorder: A randomized controlled trial. Annals of Internal Medicine.
Hammond, A. S., Sweeney, M. M., Chikosi, T. U., & Stitzer, M. L. (2021). Digital delivery of a contingency management intervention for substance use disorder: A feasibility study with DynamiCare Health. Journal of Substance Abuse Treatment, 126,
108425.
Hirshfield, S., Contreras, J., Luebe, R. Q., Swartz, J. A., Scheinmann, R., Reback, C. J., Fletcher, J. B., Kisler, K. A., Kuhns, L. M., & Molano, L. F. (2021). Engagement in HIV Care Among New York City Transgender Women of Color: Findings from the Peer-Led, TWEET Intervention, a SPNS Trans Women of Color Initiative. AIDS and Behavior, 25(1), 20-30. AIDS and Behavior
25(1), 20-30.
Hsia, S. H., Nisis, M. L., Lee, M. L., Goldstein, C., & Friedman, T. C. (2021). Metabolic parameters in smokers undergoing smoking reduction. Journal of Clinical & Translational Endocrinology,
23, 100249.
Ingel, S.N., *Davis, L. Rudes, D.S., Hartwell, T. N., Drazdowski, T.K., McCart, M.R., Chapman, J.E., Taxman, F.S., & Sheidow, A. J. (2021). Misunderstanding and Sensemaking Among Juvenile Probation Officers Working with Evidence-Based Practices. Victims & Offenders,
17(7), 975-993.
Ingel, S.N., Smith, L.S., Rudes, D.S., & Magnuson, S. (2021). Strain and Gain: From Deprivation to Innovation within Restricted Housing Units. Deviant Behavior,
1-19. https://doi.org/10.1080/01639625.2021.1913453.
Jilani, S. M., Jones, H. E., Grossman, M., Jansson, L. M., Terplan, M., Faherty, L. J., Khodyakov, D., Patrick, S. W., & Davis, J. M. (2021). Standardizing the clinical definition of opioid withdrawal in the neonate. Journal of Pediatrics.
Karnik, N. S., Campbell, C. I., Curtis, M. E., Fiellin, D. A., Ghitza, U., Hefner, K., Hser, Y. I., McHugh, R. K., Murphy, S. M., McPherson, S. M., Moran, L., Mooney, L. J., Wu, L. T., Shmueli-Blumberg, D., Shulman, M., Schwartz, R. P., Stephens, K. A., Watkins, K. E., & Marsden, J. (2021). Core outcomes set for research on the treatment of opioid use disorder (COS-OUD): The National Institute on Drug Abuse Clinical Trials Network protocol for an e-Delphi consensus study. Trials, 22
(1), 102.
Kelty, E., Terplan, M., Greenland, M., & Preen, D. (2021). Pharmacotherapies for the treatment of alcohol use disorders during pregnancy: Time to reconsider? Drugs, 81(7),
739-748.
Kim, S. C. J., Martinez, J. E., Liu, Y., & Friedman, T. C. (2021). US Tobacco 21 is Paving the Way for a Tobacco Endgame. Tobacco Use Insights, 14,
1179173X211050396.
Kisler, K. A., Fletcher, J. B., Fehrenbacher, A. E., & Reback, C. J. (2021). Age Is associated with HIV sexual risk behaviors among trans women in Los Angeles County. AIDS Education & Prevention, 33
(6), 483-494.
Krawczyk, N., Fawole, A., Yang, J., Tofighi, B. (2021). Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review. Addiction Science & Clinical Practice
16(1):1-5.
Lee, J.D., Malone, M., McDonald, R., Cheng, A., Vasudevan, K., Tofighi, B., Garment, A., Porter, B., Goldfeld, K.S., Matteo, M., Mangat, J (2021). Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail. JAMA Network Open
(9):e2123032.
Ludwig, A., Monico, L. B., Gryczynski, J., Lertch, E., Schwartz, R. P., Fishman, M., Dionne, R., & Mitchell, S. G. (2021). Drug and sexual HIV-risk behaviors among adolescents and young adults with opioid use disorder. Journal Substance Abuse Treatment, 130,
108477.
Ludwig, A., Monico, L. B., Lertch, E., Schwartz, R. P., Fishman, M., & Mitchell, S. G. (2021). Until there’s nothing left: Caregiver resource provision to youth with opioid use disorders. Substance Abuse, 42
(4), 990-997.
Mark, K., Pace, L., Temkin, S. M., Crimmins, S., & Terplan, M. (2021). Concordance and discordance between maternal and newborn drug test results. American Journal of Obstetrics & Gynecology MFM, 3
(4), 100366.
Martin, C. E., Parlier-Ahmad, A. B., Beck, L., Scialli, A., & Terplan, M. (2021). Need for and receipt of substance use disorder treatment among adults, by gender, in the United States. Public Health Reports,
333549211041554.
Masa, R., & Sharma A. ( (2021). Invariance of the Household Food Insecurity Access Scale Across Different Groups of Adolescents and Young Adults. Food and Nutrition Bulletin, 42
(3), 437-450.
McCarthy, J. J., Jones, H. E., Terplan, M., Rudolf, V. P., & von Klimo, M. C. (2021). Changing outdated methadone regulations that harm pregnant patients. Journal of Addiction Medicine, 15
(2), 93-95.
Meredith, L. R., Baskerville, W.-A., Friedman, T. C., Hurley, B., Dixon, T., Mtume, N., Rodriguez, L., Lopez, B., Hsieh, S., & Ray, L. A. (2021). Safety Net Provider Attitudes Toward Smoking Cessation Treatment [Brief Research Report]. Frontiers in Psychiatry, 12.
Mitchell, M. M., Schwartz, R. P., Choo, T.-H., Pavlicova, M., O’Grady, K. E., Gryczynski, J., Stitzer, M. L., Nunes, E. V., & Rotrosen, J. (2021). An alternative analysis of illicit opioid use during treatment in a randomized trial of extended-release naltrexone versus buprenorphine-naloxone: A per-protocol and completers analysis. Drug & Alcohol Dependence,
219, 108422.
Mitchell, M., Kelly, S., O’Grady, K., Jaffe, J., Mitchell, S., & Schwartz, R. (2021). HIV-risk behavior among adults with opioid use disorder during 12 months following pre-trial detention: Results from a randomized trial of methadone treatment. AIDS & Behavior, 25
(4), 1247-1256.
Mitchell, S. G., Harmon-Darrow, C., Lertch, E., Monico, L. B., Kelly, S., M., Sorensen, J. L., & Schwartz, R. P. (2021). Views of barriers and facilitators to continuing methadone treatment upon release from jail among people receiving patient navigation services. Journal of Substance Abuse Treatment, 127,
108351.
Mitchell, S. G., Monico, L. B., Gryczynski, J., Fishman, M. J., O’Grady, K. E., & Schwartz, R. P. (2021). Extended-release naltrexone for youth with opioid use disorder. Journal Substance Abuse Treatment, 130,
108407.
Monico, L. B., Gryczynski, J., Lee, J. D., Dusek, K., McDonald, R., Malone, M., Sharma, A., Cheng, A., DeVeaugh-Geiss, A., & Chilcoat, H. (2021). Exploring nonprescribed use of buprenorphine in the criminal justice system through qualitative interviews among individuals recently released from incarceration. Journal Substance Abuse Treatment, 123,
108267.
Monico, L. B., Ludwig, A., Lertch, E., Dionne, R., Fishman, M., Schwartz, R. P., & Mitchell, S. G. (2021). Opioid overdose experiences in a sample of US adolescents and young adults: A thematic analysis. Addiction, 116(4),
865-873.
Monico, L. B., Ludwig, A., Lertch, E., Schwartz, R. P., Fishman, M., & Mitchell, S. G. (2021). Post-residential treatment outpatient care preferences: Perspectives of youth with opioid use disorder. Journal of Substance Abuse Treatment,
108692.
Monico, L. B., Mitchell, S. G., Gryczynski, J., Dusek, K., Oros, M., Hosler, C., Brown, B. S., Ross, T., & Schwartz, R. P. (2021). Organizational acceptability of implementing SBIRT for adolescents in primary care. Substance Use & Misuse, 56
(10), 1536-1542.
Nordeck, C.D., Riehm, K.E., Smail, E.J., Holingue, C., Kane, J.C., Johnson, R.M., Veldhuis, C.B., Kalb, L.G., Stuart, E.A., Kreuter, F., Thrul, J. (2021). Changes in drinking days among US adults during the COVID-19 pandemic. Addiction
O’Keeffe, C., Vocci, F. J., & Leshner, A (2021). Letter to the Editor regarding: Buprenorphine for opioid use disorder: The role of public funding in its development (by Barenie and Kesselheim, 2020). Drug & Alcohol Dependence, 221,
108644.
Ogunbajo, A., Storholm, E. D., Ober, A. J., Bogart, L. M., Reback, C. J., Flynn, R., Lyman, P., & Morris, S. (2021). Multilevel barriers to HIV PrEP uptake and adherence among Black and Hispanic/Latinx transgender women in Southern California. AIDS & Behavior, 25(7),
2301-2315.
Parlier-Ahmad, A. B., Terplan, M., Svikis, D. S., Ellis, L., & Martin, C. E. (2021). Recovery capital among people receiving treatment for opioid use disorder with buprenorphine. Harm Reduction Journal, 18
(1), 103.
Patel, E., Bandara, S., Saloner, B., Stuart, E. A., Goodman, D., Terplan, M., McCourt, A., White, S., & McGinty, E. E. (2021). Heterogeneity in prenatal substance use screening despite universal screening recommendations: Findings from the Pregnancy Risk Assessment Monitoring System, 2016-2018. American Journal of Obstetrics & Gynecology MFM, 3
(5), 100419.
Reback, C. J., Fletcher, J. B., & Kisler, K. A. (2021). Text messaging improves HIV care continuum outcomes among young adult trans women living with HIV: Text Me, Girl! AIDS & Behavior, 25
(9), 3011-3023.
Reback, C. J., Fletcher, J. B., & Mata, R. P. (2021). A theory-based mHealth intervention (Getting Off) for methamphetamine-using men who have sex with men: Protocol for a randomized controlled Trial. JMIR Research Protocols, 10
(2), e22572.
Reback, C. J., Kisler, K. A., & Fletcher, J. B. (2021). A novel adaptation of peer health navigation and contingency management for advancement along the HIV care continuum among transgender women of color. AIDS & Behavior, 25
(Suppl 1), 40-51.
Reback, C. J., Rünger, D., & Fletcher, J. B. (2021). Drug use is associated with delayed advancement along the HIV care continuum among transgender women of color. AIDS & Behavior, 25
(Suppl 1), 107-115.
Rindal, D. B., Asche, S. E., Gryczynski, J., Kane, S. M., Truitt, A. R., Shea, T. L., Ziegenfuss, J. Y., Schwartz, R. P., Worley, D. C., & Mitchell, S. G. (2021). De-implementing opioid use and implementing optimal pain management following dental extractions (DIODE): Protocol for a cluster randomized trial. JMIR Research Protocols, 10
(4), e24342.
Rindal, D. B., Asche, S. E., Kane, S., Truitt, A. R., Worley, D. C., Davin, L. M., Gryczynski, J., & Mitchell, S. G. (2021). Patient, provider type, and procedure type factors associated with opioid prescribing by dentists in a health care system. Journal of Pain Research, 14,
3309-3319.
Rudes, D.S., *Magnuson, S., Ingel, S.N., & Hartwell, T.N. (2021). Rights-in-Between: Resident Perceptions of and Accessibility to Rights within Restricted Housing Units. Law & Society Review,
55(2), 296-319.
Rudes, D.S., Portillo, S., & Taxman, F.S. (2021). The Legitimacy of Change: Adopting/Adapting, Implementing, and Sustaining Reforms within Community Corrections Agencies. British Journal of Criminology.
https://doi.org/10.1093/bjc/azab020.
Sanchez K, Gryczynski J, Carswell, S.B., Schwartz RP (2021). Development and feasibility of a Spanish language version of the Tobacco, Alcohol, Prescription Drug, and Illicit Substance Use (TAPS) Tool. Journal of Addiction Medicine
15(1),61–67.
Schiff, D. M., Nielsen, T. C., Hoeppner, B. B., Terplan, M., Hadland, S. E., Bernson, D., Greenfield, S. F., Bernstein, J., Bharel, M., Reddy, J., Taveras, E. M., Kelly, J. F., & Wilens, T. E. (2021). Methadone and buprenorphine discontinuation among postpartum women with opioid use disorder. American Journal of Obstetrics & Gynecology, 225
(4), 424.e421-424.e412.
Schiff, D. M., Stoltman, J. J. K., Nielsen, T. C., Myers, S., Nolan, M., Terplan, M., Patrick, S. W., Wilens, T. E., & Kelly, J. (2021). Assessing stigma towards substance use in pregnancy: A randomized study testing the impact of stigmatizing language and type of opioid use on attitudes toward mothers with opioid use disorder. Journal of Addiction Medicine.
Schwartz, R. P., Gibson, D., Pagano, A., Goldstein, A., Ibrahim, A., Doty, B., Patel, S., Vocci, F. J., & Clarke, D. E. (2021). Addiction Medicine Practice-Based Research Network (AMNet): Building partnerships. Psychiatric Services, 72
(7), 845-847.
Schwartz, R. P., Kelly, S. M., Mitchell, S. G., O’Grady, K. E., Duren, T., Sharma, A., Gryczynski, J., & Jaffe, J. H. (2021). Randomized trial of methadone treatment of arrestees: 24-month post-release outcomes. Drug & Alcohol Dependence,
218, 108392.
Shadowen, C., Wheeler, R., & Terplan, M. (2021). Patient and provider knowledge of and attitudes toward medical conditions and medication during pregnancy. Addiction Science & Clinical Practice, 16
(1), 22.
Shulman, M., Choo, T.H., Scodes, J., Pavlicova, M., Wai, J., Haenlein, P., Tofighi, B., Campbell, A,N., Lee, J.D., Rotrosen, J., Nunes, E.V. (2021). Association between methadone or buprenorphine use during medically supervised opioid withdrawal and extended-release injectable naltrexone induction failure. Journal of Substance Abuse Treatment
124.
Skeen, S. J., Cain, D., Gamarel, K. E., Hightow-Weidman, L., & Reback, C. J. (2021). mHealth for transgender and gender-expansive youth: harnessing gender-affirmative cross-disciplinary innovations to advance HIV prevention and care interventions. mHealth, 7,
37.
Snow, A., Handsman, S., Lawton, B., Burruss, K., & Oktay, J.S. (2021). Did COVID-19 change the interventions provided by oncology social workers in the epicenter of the pandemic? A natural experiment. Journal of Psychosocial Oncology, 39
(3), 1-9.
Temkin, S. M., & Terplan, M. (2021). Contributions, aspirations, and challenges of academic specialist divisions in obstetrics and gynecology. Obstetrics & Gynecology,
137(2), 374-375.
Terplan, M. (2021). Substance use and use disorder in pregnancy and postpartum. International Review of Pscyhiatry, 33
(6), 501.
Terplan, M., van Dis, J., & Temkin, S. M. (2021). Reengineering academic departments of obstetrics and gynecology to operate in a pandemic world and beyond: A joint American Gynecological and Obstetrical Society and Council of University Chairs of Obstetrics and Gynecology statement. American Journal of Obstetrics & Gynecology,
224(1), 129-130.
Tofighi, B., Lekas, H.M., Williams, S.Z., Martino, D., Blau, C., Lewis, C.F (2021). Rural and small metro area naloxone-dispensing pharmacists’ attitudes, experiences, and support for a frontline public health pharmacy role to increase naloxone uptake in New York State, 2019. Journal of Substance Abuse Treatment
129, 108372.
Tofighi, B., McNeely, J., Walzer, D., Fansiwala, K., Demner, A., Chaudhury, C.S., Subudhi, I., Schatz, D., Reed, T., Krawczyk, N. (2021). A Telemedicine Buprenorphine Clinic to Serve New York City: Initial Evaluation of the NYC Public Hospital System’s Initiative to Expand Treatment Access during the COVID-19 Pandemic. Journal of Addiction Medicine.
Waddell, E. N., Springer, S. A., Marsch, L. A., Farabee, D., Schwartz, R. P., Nyaku, A., Reeves, R., Goldfeld, K., McDonald, R. D., Malone, M., Cheng, A., Saunders, E. C., Monico, L., Gryczynski, J., Bell, K., Harding, K., Violette, S., Groblewski, T., Martin, W., . . . Lee, J. D. (2021). Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS). J Subst Abuse Treat, 128,
108389.
Ward, K. M., Falade-Nwulia, O., Moon, J., Sutcliffe, C. G., Brinkley, S., Haselhuhn, T., Katz, S., Herne, K., Arteaga, L., Mehta, S. H., Latkin, C., Brooner, R. K., & Sulkowski, M. S. (2021). Non-adherence to LDV/SOF did not predict SVR in a randomized controlled trial of HIV/HCV coinfected persons who use drugs. Journal of Infectious Diseases.
Wu, A. C., Graif, C., Mitchell, S. G., Meurer, J., & Mandl, K. D. (2021). Creative approaches for assessing long-term outcomes in children. Pediatrics, 148
(Suppl 1), s25-s32.
You, D. S., Mardian, A. S., Darnall, B. D., Chen, C. A., De Bruyne, K., Flood, P. D., Kao, M. C., Karnik, A. D., McNeely, J., Porter, J. G., Schwartz, R. P., Stieg, R. L., & Mackey, S. C. (2021). A brief screening tool for opioid use disorder: EMPOWER Study Expert Consensus Protocol. Frontiers in Medicine (Lausanne),
8, 591201.
Young-Wolff, K. C., Slama, N., Sarovar, V., Conway, A., Tucker, L. Y., Goler, N., Terplan, M., Ansley, D., Adams, S. R., & Armstrong, M. A. (2021). Association of pregnancy intentions with substance use during early pregnancy. Journal of Addiction Medicine.
2020
Alexander K, Short V, Gannon M, Goyal N, Naegle M, Abatemarco D (2020). Identified gaps and opportunities in perinatal healthcare delivery for women in treatment for opioid use disorder. Substance Abuse Journal
1-7. doi: 10.1080/08897077.2020.1803178.
Alexander K, Smith J, Clary-Muronda V, Ward J (2020). The relationship between past experience, empathy and attitudes towards poverty. Journal of Nursing Education.
59(3), 158-162.
Barbosa‐Leiker C, Campbell AN, Pavlicova M, Scodes J, Burlew AK, Hatch‐Maillette M, Mennenga SE, Mitchell SG, Novo P, Nunes EV (2020). Substance use and mental health in emerging adult vs older adult men and women with opioid use disorder. The American Journal on Addictions
29(6),536-542.
Carswell, S.B., Mitchell SG, Gryczynski J, Lertch E (2020). Computerizing NIAAA’s best practices for youth screening and brief intervention: A proof-of-concept pilot study of an automated alcohol screening and intervention resource tool. Journal of Drug Education
49(1-2), 3–14.
Comulada WS, Step M, Fletcher JB, Tanner AE, Dowshen NL, Arayasirikul S, Baker KK, ZunigaJ, Swendeman D, Medich M (2020). Predictors of Internet Health Information–Seeking Behaviors Among Young Adults Living With HIV Across the United States: Longitudinal Observational Study. Journal of Medical Internet Research
22(11), e18309.
Denny CH, Acero CS, Terplan M, Kim SY (2020). Trends in Alcohol Use Among Pregnant Women in the US, 2011–2018. American Journal of Preventive Medicine
59(5), 768-769.
Faherty LJ, Stein BD, Terplan M (2020). Consensus guidelines and state policies: the gap between principle and practice at the intersection of substance use and pregnancy. American Journal of Obstetrics & Gynecology MFM
100137.
Gerke DR, Step MM, Rünger D, Fletcher JB, Brooks RA, Davis N, Kisler KA, Reback CJ (2020). Associations Between Social Support and Social Media Use Among Young Adult Cisgender MSM and Transgender Women Living With HIV. Health Promotion Practice
21(5), 705-715.
Ghassemlou, S., Marini, C., Chemi, C., Ranjit, Y.S., Tofighi, B. (2020). Harmful smartphone applications promoting alcohol and illicit substance use: a review and content analysis in the United States. Translational Behavioral Medicine
10(5):1233-42.
Gordon MS, Mitchell SG, Blue TR, Vocci FJ, Fishman MJ, Murphy SM, CouvillionK, Maher K, Ryan D, Wenzel K, Danner ML, Jarvis DK (2020). A clinical protocol of a comparative effectiveness trial of extended-release naltrexone versus extended-release buprenorphine with individuals leaving jail. Journal of Substance Abuse Treatment
108241.
Gryczynski, J., Nordeck, C. D., Martin, R. D., Welsh, C., Schwartz, R. P., Mitchell, S. G., & Jaffe, J. H. (2020). Leveraging health information exchange for clinical research: Extreme underreporting of hospital service utilization among patients with substance use disorders. Drug and Alcohol Dependence, 107992.
Hammond AS, Antoine DG, Stitzer ML, Strain EC (2020). A Randomized and Controlled Acceptability Trial of an Internet-based Therapy among Inpatients with Co-occurring Substance Use and Other Psychiatric Disorders. Journal of Dual Diagnosis
16(4), 447-454.
Harmon-Darrow, C., Burruss, K., & Finigan-Carr, N. (2020). “We are kind of their parents”: Child welfare workers’ perspective on sexuality education for foster youth. Children and Youth Services Review, 108. Children and Youth Services Review, 108.
doi:10.1016/j.childyouth.2019.104565.
Hochstatter KR, Akhtar WZ, Dietz S, Pe-Romashko K, Gustafson DH, Shah DV, Krechel S, Liebert C, Miller R, El-Bassel N, Westergaard RP (2020). Potential Influences of the COVID-19 Pandemic on Drug Use and HIV Care Among People Living with HIV and Substance Use Disorders: Experience from a Pilot mHealth Intervention AIDS Behav
2020 Jul;25(2):354-359. doi: 10.1007/s10461-020-02976-1. PMID: 32705370; PMCID: PMC7376523.
Hochstatter KR, Hull SJ, Sethi AK, Burns ME, Mundt MP, Westergaard RP (2020). Promoting Safe Injection Practices, Substance Use Reduction, Hepatitis C Testing, and Overdose Prevention Among Syringe Service Program Clients Using a Computer-Tailored Intervention: Pilot Randomized Controlled Trial J Med Internet Res
2020 Sep 29;22(9):e19703. doi: 10.2196/19703. PMID: 32990630; PMCID: PMC7556373.
Holloway IW, Jordan SP, Dunlap SL, Ritterbusch A, Reback CJ (2020). Leveraging social networks and technology for HIV prevention and treatment with transgender women. AIDS Education & Prevention
32(2), 83-101.
John, WS, Grover K, Greenblatt LH, Schwartz RP, Wu LT (2020). E-Cigarette Use Among AdultPrimary Care Patients: Results from a Multisite Study. Journal of General Internal Medicine
35(1), 268-275.
Kelly, S. M., Schwartz, R. P., O’Grady, K. E., Mitchell, S. G., Duren, T., Sharma A., & Jaffe, J. H. (2020). Impact of methadone treatment initiated in jail on subsequent arrest. Journal of Substance Abuse Treatment
,108006.
Ko JY, Tong VT, Haight SC, Terplan M, Stark L, Snead C, Schulkin J (2020). Obstetrician–gynecologists’ practices and attitudes on substance use screening during pregnancy. Journal of Perinatology
40(3), 422-432.
Lounsbury DW, Mitchell SG, Dusek KA, Li JZ, Kirk AS, Oros M, Hosler C, Schwartz RP, Gryczynski J, Monico LB, Brown BS (2020). Application of system dynamics to inform a model of adolescent SBIRT implementation in primary care settings. The Journal of Behavioral Health Services & Research
47(2), 230–244.
Martin CE, Scialli A, Terplan M (2020). Unmet substance use disorder treatment need among reproductive age women. Drug & Alcohol Dependence
206, 107679.
Mitchell MM, Gryczynski J, Mitchell SG, Kelly SM, O’Grady KE, Monico LB, Schwartz RP (2020). A latent class analysis of HIV risk factors among men and women with opioid use disorder in pre-trial detention. AIDS and Behavior
24(6), 1776–1783.
Mitchell MM, Mendelson J, Gryczynski J, Carswell, S.B., Schwartz RP (2020). A novel telehealth platform for alcohol use disorder treatment: Preliminary evidence of reductions in drinking. The American Journal of Drug and Alcohol Abuse
46(3), 297–303.
Mitchell SG, Gryczynski J, Schwartz RP, Kirk AS, Dusek K, Oros M, Hosler C, O’Grady KE, Brown BS (2020). Adolescent SBIRT implementation: Generalist vs. Specialist models of service delivery in primary care. Journal of Substance Abuse Treatment
111, 67-72.
Monico LB, Ludwig A, Lertch E, Dionne R, Fishman M, Schwartz RP, Mitchell SG (2020). Opioid overdose experiences in a sample of US adolescents and young adults: A thematic analysis. Addiction.
Monico LB, Ludwig A, Lertch E, Mitchell SG (2020). Using timeline methodology to visualize treatment trajectories of youth and young adults following inpatient opioid treatment. International Journal of Qualitative Methods
19, 1609406920970106.
Monico LB, Oros M, Smith S, Mitchell SG, Gryczynski J, Schwartz R (2020). One million screened: Scaling up SBIRT and buprenorphine treatment in hospital emergency departments across Maryland. The American Journal of Emergency Medicine
38(7), 1466-1469.
Monico, L., Gryczynski, J., Lee, J.D., Dusek, K., McDonald, R., Malone, M., Sharma A., Cheng, A, DeVeaugh-Geiss, A., & Chilcoat, H. (2020). Exploring nonprescribed use of buprenorphine in the criminal justice system through qualitative interviews among individuals recently released from incarceration. Journal of Substance Abuse Treatment, 123
, 108267.
Murphy SM, Jeng PJ, Poole SA, Jalali A, Vocci FJ, Gordon MS, Woody GE, Polsky D (2020). Health and economic outcomes of treatment with extended-release naltrexone among pre-release prisoners with opioid use disorder (HOPPER): protocol for an evaluation of two randomized effectiveness trials. Addiction Science & Clinical Practice
15, 1-11.
Nordeck C.D., Welsh C., Schwartz R.P., Mitchell S.G., O’Grady K.E., Dunlap L, et al. (2020). Navigation Services to Avoid Rehospitalization among Medical/Surgical Patients with Comorbid Substance Use Disorder: Rationale and Design of a Randomized Controlled Trial. Journal of Psychiatry and Brain Science.
Nordeck, C.D., Buresh, M., Krawczyk, N., Fingerhood, M., Agus, D. (2020). Adapting a low-threshold buprenorphine program for vulnerable populations during the COVID-19 pandemic. Journal of Addiction Medicine.
Nordeck, C.D., Gryczynski, J., O’Grady, K.E., Polak, K., Svikis D.S., McNeely, J., Wu, L.T., Schwartz, R.P. (2020). Comparison of timeline follow-back self-report and oral fluid testing to detect substance use in adult primary care patients. Drug and Alcohol Dependence.
Oktay, J.S., Rohan, E.A., Burruss, K., Callahan, C., Schapmire, T.J., & Zebrack, B. (2020). Oncology social work intervention index (OSWii): An instrument to measure oncology social work interventions to advance research. Journal of Psychosocial Oncology, 39
(5), 1-12.
Olsen N, Eagan A, Romutis K, Terplan M, Martin CE (2020). Evaluation of a new departmental policy to decrease routine opioid prescribing after vaginal delivery. American Journal of Obstetrics & Gynecology MFM
2(3), 100156.
Owens L, Gilmore K, Terplan M, Prager S, Micks E (2020). Providing reproductive health services for women who inject drugs: a pilot program. Harm Reduction Journal
17(1), 47.
Premkumar A, Grobman WA, Terplan M, Miller ES (2020). In Reply. Obstetetrics & Gynecology
135(4), 975-976.
Reback CJ, Rünger D (2020). Technology use to facilitate health care among young adult transgender women living with HIV. AIDS Care
32(6), 785–792.
Reback CJ, Rusow JA, Cain D, Benkeser D, Arayasirikul S, Hightow-Weidman L, Horvath KJ (2020). Technology-Based Stepped Care to Stem Transgender Adolescent Risk Transmission: Protocol for a Randomized Controlled Trial (TechStep). JMIR Research Protocols
9(8), e18326.
Schiff, DM, Nielsen T, Hoeppner BB, Terplan M, Hansen H, Bernson D, Diop H, Bharel M, Krans EE, Selk S (2020). Assessment of racial and ethnic disparities in the use of medication to treat opioid use disorder among pregnant women in Massachusetts. JAMA Network Open
3(5),e205734-e205734.
Schiff, DM, Nielsen T, Terplan M, Wakeman SE, Yule AM, Mehta PK, Taveras EM, Wilens TE (2020). Improving measures of dyadic outcomes in perinatal substance use research. Addiction (Abingdon, England)
115(9), 1787-1788.
Schwartz, R.P., Kelly, S.M., Mitchell, S.G., O’Grady, K.E., Sharma A., Jaffe, J.H. (2020). Methadone treatment of arrestees: A randomized clinical trial. Drug and Alcohol Dependence.
Smid MC, Schauberger CW, Terplan M, Wright TE (2020). Early lessons from maternal mortality review committees on drug-related deaths—time for obstetrical providers to take the lead in addressing addiction. American Journal of Obstetrics & Gynecology MFM
2(4), 100177.
Sufrin C, Sutherland L, Beal L, Terplan M, Latkin C, Clarke JG (2020). Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study. Addiction
115(11), 2057-2065.
Temkin SM, Terplan M (2020). Executive Summary of the Early-Onset Breast Cancer Evidence Review Conference. Obstetrics & Gynecology
136(3), 635.
Terplan M (2020). Can Perinatal Quality Collaboratives Address Racial (In)Justice? American Journal of Public Health
110(12), 1728-1729.
Tofighi, B., Aphinyanaphongs, Y., Marini, C., Ghassemlou, S., Nayebvali, P., Metzger, I., Raghunath, A., Thomas, S. (2020). Detecting illicit opioid content on Twitter. Drug and Alcohol Review
39(3); 205-208.
Tofighi, B., El Shahawy, O., Segoshi, A., Moreno, K.P., Badiei, B., Sarker, A., Krawczyk, N. (2020). Assessing perceptions about medications for opioid use disorder and Naloxone on Twitter. Journal of Addictive Diseases
20:1-9.
Zarkin GA, Orme S, Dunlap LJ, Kelly SM, Mitchell SG, O’Grady KE, Schwartz RP (2020). Cost and cost-effectiveness of interim methadone treatment and patient navigation initiated in jail. Drug & Alcohol Dependence
217, 108292.
Zerden, L. D. S., Guan, T., Lombardi, B. M., Sharma A., & Garcia-Rico, Y. (2020). Psychosocial Interventions in Office-Based Opioid Treatment: A Systematic Review. Journal of the Society for Social Work and Research, 11
(1), 000-000.
Zerden, L. D. S., Lombardi, B. M., Sharma A., Richman, E. (2020). Interprofessional Teams and the Office-Based Opioid Treatment (OBOT) Workforce. Health, Interprofessional Practice and Education.
2019
Adam A, Schwartz RP, Wu LT, Subramaniam G, Laska E, Sharma G, Mili S, McNeely J (2019). Electronic self-administered screening for substance use in adult primary care patients: feasibility and acceptability of the tobacco, alcohol, prescription medication, and other substance use (myTAPS) screening tool Addiction Science & Clinical Practice
14(1):39. doi: 10.1186/s13722-019-0167-z.PMID: 31615549.
Alexander K, Kronk R, Sekula K, Short V, Abatemarco D (2019). Implementation of a mindfulness intervention with women in treatment for opioid use disorder. Issues in Mental Health Nursing, 40(8), 690-696.
Anderson-Carpenter KD, Fletcher JB, Swendeman D, Reback CJ (2019). Associations Between Sociodemographic Characteristics and Substance Use Disorder Severity Among Methamphetamine-using Men Who Have Sex with Men Substance Use & Misuse
54(11):1763-1773. doi: 10.1080/10826084.2019.1610445. Epub 2019 May 10. PMID: 31075997.
Berland, N., Lugassy, D., Fox, A., Goldfeld, K., Oh, S. Y., Tofighi, B., & Hanley, K. (2019). Use of online opioid overdose prevention training for first-year medical students: A comparative analysis of online versus in-person training. Substance abuse
, 40(2), 240–246.
Blue TR, Gordon MS, Schwartz RP, Couvillion K, Vocci FJ, Fitzgerald TT, O’Grady KE (2019). Longitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphine Addiction Science & Clinical Practice
14(1):45. doi: 10.1186/s13722-019-0172-2. PMID:31787108.
Brincks AM, Shiu-Yee K, Metsch LR, Del Rio C, Schwartz RP, Jacobs P, Osorio G, Sorensen JL, Feaster DJ (2019). Physician Mistrust, Medical System Mistrust, and Perceived Discrimination: Associations with HIV Care Engagement and Viral Load AIDS and Behavior
23: 2859-2869.
Carrico AW, Gómez W, Reback CJ (2019). Evidence-based Alcohol and Substance Use Disorder Treatment with Sexual and Gender Minorities. In JE. Pachankis & SA, Safren (Eds.), Handbook of Evidence-based Mental Health Practices with Sexual and Gender Minorities
New York: Oxford Univertiy Press, pp. 222-243.
Cruz-Oliver DM, Tseng TY, Mitchell MM, Catanzarite Z, Budhathoki C, Smith TJ, Rushton C, Knowlton A (2019). Support Network Factors Associated with Naming a Health Care Decision-Maker and Talking about Advance Care Planning among People Living with Human Immunodeficiency Virus Journal Pain Symptom Management
58(6):1040-1047. doi: 10.1016/j.jpainsymman.2019.08.019. Epub 2019 Aug 22. PMID: 31446009.
Elkashef A, Brasic JR, Cantilena LR, Kahn R, Chiang N, Ye WG, Zhou Y, Mojsiak J, Warren K, Crabb A, Hilton J, Wong DF, and Vocci F (2019). A cholecystokinin B receptor antagonist and cocaine interaction, Phase I study CNS Neuroscience and Therapeutics
25(1):136-146.
Elkashef A, Vocci F (2019). Pharmacotherapy of Cocaine Addiction In Addiction Medicine
(ed.) Johnson, BA. Springer Verlag.
Gordon MS, Vocci FJ, Taxman F, Fishman M, Sharma B, Blue TR, O’Grady KE (2019). A Randomized Controlled Trial of Buprenorphine for Probationers and Parolees: Bridging the Gap into Treatment Contemporary Clinical Trials
79:21-27. doi: 10.1016/j.cct.2019.02.009. Epub 2019 Feb 20. PMID: 30797042.
Gryczynski J, Mitchell SG, Schwartz RP, Kelly SM, Dušek K, Monico L, O’Grady KE, Brown BS, Oros M, Hosler C (2019). Disclosure of Adolescent Substance Use in Primary Care: Comparison of Routine Clinical Screening and Anonymous Research Interviews Journal of Adolescent Health
64(4):541-543. doi: 10.1016/j.jadohealth.2018.10.009. Epub 2018 Dec 18. PMID: 30578116.
Gryczynski J, Nichols H, Schwartz RP, Mitchell SG, Hill P, Wireman K (2019). Fentanyl exposure and preferences among individuals starting treatment for opioid use disorder Drug and Alcohol Dependence
204:107515. doi: 10.1016/j.drugalcdep.2019.06.017. PMID: 31525569.
Hansen ED, Mitchell MM, Cruz Oliver DM, Alghanim FA, Walter M, Case AA, Smith T, Knowlton AR (2019). Chronic Pain, Functional Status, and Life Satisfaction Are Associated With Patients Living With HIV Discussing Advance Care Planning With Their Family or Friends Journal Pain Symptom Management
57(5):961-965. doi: 10.1016/j.jpainsymman.2019.02.018. Epub 2019 Feb 25. PMID: 30818027.
Hochstatter KR, Gustafson DH Sr, Landucci G, Pe-Romashko K, Maus A, Shah DV, Taylor QA, Gill EK, Miller R, Krechel S, Westergaard RP (2019). A Mobile Health Intervention to Improve Hepatitis C Outcomes Among People With Opioid Use Disorder: Protocol for a Randomized Controlled Trial JMIR Res Protoc
2019 Aug 1;8(8):e12620. doi: 10.2196/12620. PMID: 31373273; PMCID: PMC6694728.
Hussong AM, Gottfredson NC, Bauer DJ, Curran PJ, Haroon M, Chandler R, Kahana SY, Delaney JAC, Altice FL, Beckwith CG, Feaster DJ, Flynn PM, Gordon MS, Knight K, Kuo I, Ouellet LJ, Quan VM, Seal DW, Springer SA (2019). Approaches for Creating Comparable Measures of Alcohol use Symptoms: Harmonization with Eight Studies of Criminal Justice populations Drug and Alcohol Dependence
194:59-68. doi: 10.1016/j.drugalcdep.2018.10.003. Epub 2018 Oct 23. PMID: 30412898.
John WS, Zhu H, Mannelli P, Subramaniam GA, Schwartz RP, McNeely J, Wu LT (2019). Prevalence and Patterns of Opioid Misuse and Opioid Use Disorder Among Primary Care Patients who Use Tobacco Drug and Alcohol Dependence
194:468-475. doi: 10.1016/j.drugalcdep.2018.11.011. Epub 2018 Nov 26. PMID: 30513477.
Knight DK, Blue TR, Flynn PM, Knight K (2019). The TCU Drug Screen 5: Identifying justice-involved individuals with substance use disorders Journal of Offender Rehabilitation
57(8): 525-537.
Krawczyk N, Buresh M, Gordon MS, Blue TR, Fingerhood MI, Agus D (2019). Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: Addressing a critical care gap Journal of Substance Abuse Treatment
103:1-8. doi: 10.1016/j.jsat.2019.05.002. Epub 2019 May 9. PMID: 31229187.
Malone, M., McDonald, R., Vittitow, A., Chen, J., Obi, R., Schatz, D., Tofighi, B., Garment, A., Kermack, A., Goldfeld, K., Gold, H. (2019). Extended-release vs. oral naltrexone for alcohol dependence treatment in primary care (XON). Contemporary clinical trials
81, pp.102-109.
Monico LB, Mitchell SG, Dusek K, Gryczynski J, Schwartz RP, Oros M, Hosler C, O’Grady KE, Brown BS (2019). A Comparison of Screening Practices for Adolescents in Primary Care After Implementation of Screening, Brief Intervention, and Referral to Treatment. Journal of Adolescent Health Journal of Adolescent Health
65(1):46-50. doi: 10.1016/j.jadohealth.2018.12.005. Epub 2019 Mar 6. PMID: 30850312.
Naar S, Hudgens MG, Brookmeyer R, Idalski Carcone A, Chapman J, Chowdhury S, Ciaranello A, Comulada WS, Ghosh S, Horvath KJ, Ingram L, LeGrand S, Reback CJ, Simpson K, Stanton B, Starks T, Swendeman D (2019). Improving the Youth HIV Prevention and Care Cascades: Innovative Designs in the Adolescent Trials Network for HIV/AIDS Interventions AIDS Patient Care STDS
33(9):388-398. doi: 10.1089/apc.2019.0095. PMID: 31517525.
Palamar, J.J., Salomone, A., Bigiarini, R., Vincenti, M., Acosta, P., Tofighi, B. (2019). Testing Hair for Fentanyl Exposure: A Method to Inform Harm Reduction Behavior among Individuals Who Use Heroin. American journal of drug and alcohol abuse
45 (1), 90-96.
Parisi, A., Sharma A., Howard, M. O., & Wilson, A. B. (2019). The relationship between substance misuse and complicated grief: A systematic review. Journal of Substance Abuse Treatment.
Passaro RC, Ramsey K, Segura ER, Lake JE, Reback CJ, Clark JL, Shoptaw S (2019). Speed kills: Associations Between Methamphetamine Use, HIV Infection, Tobacco Use, and Accelerated Mortality Among Gay and Bisexual Men in Los Angeles, CA 20years after Methamphetamine Dependence Treatment Drug and Alcohol Dependence
195:164-169. doi: 10.1016/j.drugalcdep.2018.06.036. Epub 2018 Nov 11. PMID: 30429048.
Reback CJ, Clark K, & Fletcher JB (2019). TransAction: A Homegrown, Theory-based, HIV Risk Reduction Intervention for Extremely High-risk Transgender Women Experiencing Multiple Health Disparities Sexuality Research and Social Policy
16(4): 408-418. DOI: 10.1007/s13178-018-0356-7.
Reback CJ, Clark K, Fletcher JB, Holloway IW (2019). A Multilevel Analysis of Social Network Characteristics and Technology Use on HIV Risk and Protective Behaviors Among Transgender Women AIDS and Behavior
23(5):1353-1367. doi: 10.1007/s10461-019-02391-1. PMID: 30617525.
Reback CJ, Clark KA, Rünger D, Fehrenbacher AE (2019). A Promising PrEP Navigation Intervention for Transgender Women and Men Who Have Sex with Men Experiencing Multiple Syndemic Health Disparities Journal of Community Health
44(6):1193-1203. doi: 10.1007/s10900-019-00705-x. PMID: 31317438.
Reback CJ, Fletcher JB, Fehrenbacher AE, Kisler K (2019). Text Messaging to Improve Linkage, Retention, and Health Outcomes Among HIV-Positive Young Transgender Women: Protocol for a Randomized Controlled Trial (Text Me, Girl!) JMIR Res Protoc.
8(7):e12837. doi: 10.2196/12837. PMID: 31359867.
Reback CJ, Fletcher JB, Leibowitz AA (2019). Cost effectiveness of text messages to reduce methamphetamine use and HIV sexual risk behaviors among men who have sex with men Journal of Substance Abuse Treatment
100:59-63. doi: 10.1016/j.jsat.2019.02.006. Epub 2019 Feb 27. PMID: 30898329.
Reback CJ, Fletcher JB, Swendeman DA, Metzner M (2019). Theory-Based Text-Messaging to Reduce Methamphetamine Use and HIV Sexual Risk Behaviors Among Men Who Have Sex with Men: Automated Unidirectional Delivery Outperforms Bidirectional Peer Interactive Delivery AIDS and Behavior
23(1):37-47. doi: 10.1007/s10461-018-2225-z. PMID: 30006792.
Reback CJ, Kisler KA, Fletcher JB (2019). A novel adaptation of peer health navigation and contingency management for advancement along the HIV care continuum among transgender women of color. AIDS and Behavior, 1-12
Reback CJ, Larkins S, & Clark K (2019). Motivations for a Casual or Occasional Sexual Encounter with a Man and/or Transgender Woman among Heterosexual Men: Toward a Better Understanding of Atypical Sexual Partnering Sexuality and Culture
2019 Jun;23(2):359-374. doi: 10.1007/s12119-018-9576-5. Epub 2018 Oct 16. PMID: 31105424.
Reback CJ, Rünger D, Fletcher JB (2019). Drug use is associated with delayed advancement along the HIV care continuum among transgender women of color. AIDS and Behavior, 1-9.
Saxon AJ, Akerman SC, ChihChin L, Sullivan MA, Silverman BL, Vocci FJ (2019). Extended-release naltrexone (XR-NTX) for opioid use disorder in clinical practice: Vivitrol’s Cost and Treatment Outcomes Registry Addiction
113(8): 1477-1487, 2018. DOI:10.1111/add.14199.
Schwartz RP, Kelly SM, Mitchell SG, Gryczynski J, O’Grady KE, Jaffe JH (2019). Initiating methadone in jail and in the community: Patient differences and implications of methadone treatment for reducing arrests Journal of Substance Abuse Treatment
97:7-13. doi: 10.1016/j.jsat.2018.11.006. Epub 2018 Nov 19. PMID:30577902.
Short V, Cambareri K, Gannon M, Alexander K, Abatemarco D (2019). A pilot study to assess breastfeeding knowledge, attitudes, and perceptions of individuals who work in perinatal opioid use disorder treatment settings. Breastfeeding Medicine
14(5):307-312.
Soares WE, Wilson D, Gordon MS, Lee JD, Nunes EV, O’Brien, CP, Shroff M, Friedmann PD (2019). Incidence of Future Arrests in Adults involved in the Criminal Justice System with Opioid Use Disorder receiving Extended Release Naltrexone compared to Treatment as Usual Drug and Alcohol Dependence
194, 482-486 doi: 10.1016/j.drugalcdep.2018.10.035. Epub 2018 Dec 3. PMID:30522048.
Tofighi, B., Chemi, C., Valcarcel, J., Hein, P., Marini, C., Hu, L. (2019). A validated assessment and critical analysis of commercial smartphone applications targeting alcohol and illicit substance use. . Journal of Medical Informatics Research mHealth and uHealth
7 (4), e11831.
Tofighi, B., Isaacs, N., Byrnes-Enoch, H., Lakew, R., Lee, J.D., Berry, C., Schatz, D. (2019). Expanding treatment for opioid use disorder in publicly funded primary care clinics: Exploratory evaluation of the NYC health+ hospitals buprenorphine ECHO program. Journal of substance abuse treatment
106, pp.1-3.
Tofighi, B., Lee, J.D., Sherman, S., Schatz, D., El-Shahawy, O (2019). Smoking patterns and preferences for technology assisted smoking cessation interventions among adults with opioid and alcohol use disorders. Journal of Substance Use
24(6), pp.660-665.
Tofighi, B., Leonard, N., Greco, P., Hadavand, A., Acosta, M.C., Lee, J.D. (2019). Technology use patterns among patients enrolled in inpatient detoxification treatment. Journal of addiction medicine
13(4):279.
Tofighi, B., Sindhu, S.S., Chemi, C., Lewis, C.F., Dickson, V.V., Lee, J.D. (2019). Perspectives on the HIV continuum of care among adult opioid users in New York City: a qualitative study. Harm reduction journal
16(1), p.58.
Tofighi, B., Sindhu, S.S., Lee, J.D., Chemi, C., Leonard, N.R. (2019). Engagement in the hepatitis C care continuum among people who use drugs. J Substance Use
1-7.
Tofighi, B., Williams, A.R., Chemi, C., Suhail-Sindhu, S., Dickson, V., Lee, J.D. (2019). Patient Barriers and Facilitators to Medications for Opioid Use Disorder in Primary Care. Substance use & misuse
54(14), pp.2409-2419.
Velasquez, M., Flannery, M., Badolato, R., Vittitow, A., McDonald, R.D., Tofighi, B., Garment, A.R., Giftos, J., Lee, J.D. (2019). Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail. Addiction science & clinical practice
14(1), p.37.
Vocci F (2019). Clinical Trials in Substance Using Populations In Principles of Addiction Medicine, 6th Edition
Eds. Miller SC, Fiellin DA, Rosenthal RN, Saitz R. Wolters Kluwer.
Westergaard RP, Hochstatter KR, Andrews PN, Kahn D, Schumann CL, Winzenried AE, Sethi AK, Gangnon RE, Sosman JM (2019). Effect of Patient Navigation on Transitions of HIV Care After Release from Prison: A Retrospective Cohort Study AIDS Behav
2019 Sep;23(9):2549-2557. doi: 10.1007/s10461-019-02437-4. PMID: 30790170; PMCID: PMC6703963.
Wiechelt S, Gryczynski J, Hawk Lessard K (2019). Chapter 7: Cultural and historical trauma among Native Americans In (Brandell JR, & Ringel S, Eds.). Trauma: Contemporary Directions in Trauma Theory, Research, and Practice (2nd Edition)
New York: Columbia University Press (pp. 167-205).
Wiese AL, Blue TR, Knight DK, Knight K (2019). The validity of TCU Drug Screen 5 for identifying substance use disorders among justice-involved youth Federal Probation
83: 65-70.
2018
Alexander K (2018). Integrative review of the relationship between mindfulness-based parenting interventions and depression symptoms in parents. Journal of Obstetric, Gynecology and Neonatal Nursing
41(2), 184-190.
Barbosa C, Wedehase B, Dunlap L, Mitchell SG, Dusek K, Schwartz RP, Gryzcynski J, Kirk AS, Oros M, Hosler C, O’Grady KE, Brown BS (2018). Start-Up Costs of SBIRT Implementation for Adolescents in Urban U.S. Federally Qualified Health Centers Journal of Studies on Alcohol and Drugs
79(3):447-454. PMID:29885153.
Carswell, S.B., Gordon MS, Gryczynski J, and Tangires S (2018). The daily progress system: A proof of concept pilot study of a recovery support technology tool for outpatient substance abuse treatment The American Journal of Drug and Alcohol Abuse
Published online: 30 May 2018.
Chen DT, Ko TM, Allen AA, Bonnie RJ, Suratt CE, Appelbaum PS, Nunes EV, Friedmann PD, Lee JD, Gordon MS, McDonald R, Wilson D, Boney TY, Murphy SM, and O’Brien CP (2018). Personal control over decisions to participate in research by persons with histories of both substance use disorders and criminal justice supervision Journal of Empirical Research on Human Research Ethics
13(2):160-172. doi: 10.1177/1556264618755243. Epub 2018 Feb 20.PMID: 29460668.
Clark K, Fletcher JB, Holloway IW, Reback CJ (2018). Structural Inequities and Social Networks Impact Hormone Use and Misuse Among Transgender Women in Los Angeles County Archives of Sexual Behavior
47(4):953-962. doi: 10.1007/s10508-017-1143-x. Epub 2018 Jan 8. PMID: 29313190.
Dunlap LJ, Zarkin GA, Orme S, Meinhofer A, Kelly SM, O’Grady KE, Gryczynski J, Mitchell SG, Schwartz RP (2018). Re-engineering methadone-Cost-effectiveness analysis of a patient-centered approach to methadone treatment Journal of Substance Abuse Treatment
94:81-90. doi: 10.1016/j.jsat.2018.07.014. Epub 2018 Jul 31. PMID: 30243422.
Fletcher JB, Swendeman D, Reback CJ (2018). Associations Between Major Depressive Episode, Methamphetamine Use Disorder Severity, and Engagement in Sexual Risk-Taking Among Methamphetamine-Using Men Who Have Sex with Men AIDS and Behavior
22(5):1461-1466. doi: 10.1007/s10461-017-1974-4. PMID: 29164354.
Fletcher JB, Swendeman D, Reback CJ (2018). Mental Health and Substance Use Disorder Comorbidity among Methamphetamine-Using Men Who have Sex with Men Journal of Psychoactive Drugs
50(3):206-213. doi: 10.1080/02791072.2018.1447173. Epub 2018 Apr 2. PMID: 29608132.
Friedmann PD, Wilson D, Nunes EV, Hoskinson Jr R, Lee JD, Gordon MS, Murphy SM, Bonnie RJ, Chen DT, Boney TY, O’Brien CP (2018). Do patient characteristics moderate the effect of extended-release naltrexone (XR-NTX) for opioid use disorder? Journal of Substance Abuse Treatment
Available at: http://dx.doi.org/10.1016/j.jsat.2017.01.018.
Gordon MS, Blue TR, Couvillion K, Schwartz RP, O’Grady KE, Fitzgerald TT, Vocci FJ (2018). Initiating buprenorphine treatment prior to versus after release from prison: Arrest outcomes Drug and Alcohol Dependence
188:232-238. doi: 10.1016/j.drugalcdep.2018.04.010. Epub 2018 May 12. PMID: 29783095.
Gordon MS, Crable EL, Carswell, S.B., Leopold J, Hodo-Powell J, McKenzie M, and Rich JD (2018). A randomized controlled trial of intensive case management (Project Bridge) for HIV-infected probationers and parolees AIDS and Behavior
22(3):1030-1038. doi: 10.1007/s10461-017-2016-y. PMID: 29273946.
Gryczynski J, Carswell, S.B., O’Grady KE, Mitchell SG, Schwartz RP (2018). Gender and ethnic differences in primary care patients’ response to computerized vs. in-person brief intervention for illicit drug misuse. Journal of Substance Abuse Treatment
84:50-56. doi: 10.1016/j.jsat.2017.10.009. Epub 2017 Nov 7. PMID: 29195593.
Gryczynski, J., Schwartz, R. P., Fishman, M., Nordeck, C.D., Grant, J., Nidich, S., Rothenberg, S., & O’Grady, K. E. (2018). Integration of Transcendental Meditation®(TM) into alcohol use disorder (AUD) treatment. Journal of Substance Abuse Treatment, 87, 23-30.
John WS, Zhu H, Mannelli P, Schwartz RP, Subramaniam GA, Wu LT (2018). Prevalence, patterns, and correlates of multiple substance use disorders among adult primary care patients Drug and Alcohol Dependence
187:79-87. doi: 10.1016/j.drugalcdep.2018.01.035. Epub 2018 Mar 27. PMID: 29635217.
Lee, J.D., Tofighi, B., McDonald, R.D., Campbell, A.N.C., Hu, M.C., Nunes, E.V. (2018). Acceptability and Effectiveness of a Web-Based Psychosocial Intervention among Criminal Justice Involved Adults. Health & Justice
5(1):3.
Mitchell MM, Hansen ED, Tseng TY, Shen M, Rushton C, Smith T, Hutton N, Wolfe J, Bone L, Keruly J, Wissow L, Catanzarite Z, Knowlton AR (2018). Correlates of Patterns of Health Values of African Americans Living With HIV/AIDS: Implications for Advance Care Planning and HIV Palliative Care Journal Pain Symptom Management
56(1):53-62. doi: 10.1016/j.jpainsymman.2018.02.020. Epub 2018 Mar 8. PMID: 29526613.
Mitchell MM, Isenberg SR, Maragh-Bass AC, Knowlton AR (2018). Chronic Pain Predicting Reciprocity of Support Among Vulnerable, Predominantly African-American Persons Living with HIV/AIDS AIDS and Behavior
22(6):2002-2007. doi: 10.1007/s10461-017-1775-9. PMID: 28451889.
Mitchell SG, Gryczynski J, Schwartz RP (2018). Commentary on “The More Things Change: Buprenorphine/Naloxone Diversion Continues While Treatment is Inaccessible” Journal of Addiction Medicine
12(6):424-425. doi: 10.1097/ADM.0000000000000437. PMID:30095564.
Mitchell SG, Monico LB, Lertch E, Kelly SM, Gryczynski J, Jaffe J, O’Grady KE, & Schwartz RP (2018). Counseling staff’s views of patient-centered methadone treatment: Changing program rules and staff roles The Journal of Behavioral Health Services and Research
45(3):506-515. doi: 10.1007/s11414-018-9603-1. PMID: 29536342.
Mitchell SG, Monico LB, Stitzer M, Matheson T, Sorensen JL, Feaster DJ, Schwartz RP, Metsch L (2018). How patient navigators view the use of financial incentives to influence study involvement, substance use, and HIV treatment. Journal of Substance Abuse Treatment
94:18-23. doi: 10.1016/j.jsat.2018.07.009. Epub 2018 Jul 22. PMID: 30243412.
Monico LB, Gryczynski J, Schwartz RP, Jaffe JH, O’Grady KE, & Mitchell SG (2018). Treatment outcomes among a cohort of African American buprenorphine patients: Follow-up at 12-months. The American Journal of Drug and Alcohol Abuse
44(6):604-610. doi: 10.1080/00952990.2018.1461877. Epub 2018 May 2. PMID: 29718715.
Monico LB, Mitchell SG (2018). Patient perspectives on transitioning from prescription opioids to heroin and the role of route of administration Substance Abuse Treatment, Prevention, and Policy
13(1):4. doi: 10.1186/s13011-017-0137-y. PMID: 29378623.
Nordeck C.D., Welsh C., Schwartz R.P., Mitchell S.G., Cohen A., O’Grady K.E., Gryczynski J. (2018). Rehospitalization and substance use disorder (SUD) treatment entry among patients seen by a hospital SUD consultation liaison service. Drug and Alcohol Dependence.
Nunes EV, Gordon MS, Friedmann PD, Fishman MJ, Lee JD, Chen DT, Hi MC, Boney TB, Wilson D, O’Brien CP (2018). Relapse to opioid use disorder after inpatient treatment: Protective effect of injection naltrexone . Journal of Substance Abuse Treatment
Available at: http://dx.doi.org/10.1016/j.jsat.2017.04.016.
Reback CJ, Clark K, Holloway IW, Fletcher JB (2018). Health Disparities, Risk Behaviors and Healthcare Utilization Among Transgender Women in Los Angeles County: A Comparison from 1998-1999 to 2015-2016 AIDS and Behavior
22(8):2524-2533. doi: 10.1007/s10461-018-2165-7. PMID: 29804273.
Reback CJ, Fletcher JB (2018). Elevated HIV and STI Prevalence and Incidence Among Methamphetamine-Using Men Who Have Sex With Men in Los Angeles County AIDS Education and Prevention
30(4):350-356. doi: 10.1521/aeap.2018.30.4.350. PMID: 30148668.
Reback CJ, Fletcher JB, Swendeman D (2018). Associations between Sociodemographic Characteristics and Sexual Risk Behaviors among Methamphetamine-using Men who Have Sex with Men Substance Use & Misuse
53(11):1826-1833. doi: 10.1080/10826084.2018.1436566. Epub 2018 Feb 12. PMID: 29432057.
Reback CJ, Rünger D, Fletcher JB, Swendeman D (2018). Ecological momentary assessments for self-monitoring and counseling to optimize methamphetamine treatment and sexual risk reduction outcomes among gay and bisexual men Journal of Substance Abuse Treatment
92:17-26. doi: 10.1016/j.jsat.2018.06.005. Epub 2018 Jun 15. PMID: 30032940.
Saxon AJ, Akerman SC, Liu CC, Sullivan MA, Silverman BL, Vocci FJ (2018). Extended-release naltrexone (XR-NTX) for opioid use disorder in clinical practice: Vivitrol’s Cost and Treatment Outcomes Registry Addiction
113(8):1477-1487. doi: 10.1111/add.14199. Epub 2018 Apr 1. PMID: 29493836.
Schwartz RP, Mitchell MM, O’Grady KE, Kelly SM, Gryczynski J, Mitchell SG, Gordon MS, Jaffe JH (2018). Pharmacotherapy for opioid addiction in community corrections International Review of Psychiatry
30(5):117-135. doi: 10.1080/09540261.2018.1524373. Epub 2018 Dec 6. PMID: 30522370.
Soares W, Wilson D, Rathlev N, Lee J, Gordon MS, Nunes E, O’Brien CP, Friedmann P (2018). Healthcare Utilization in Adults with Opioid Dependence receiving Extended Release Naltrexone compared to Treatment as Usual Journal of Substance Abuse Treatment
Available at: http://dx.doi.org /10.1016/j.jsat.2017.05.009.
Tofighi, B., Hein, P., Carvalho, A.M., Lee, J.D., Leonard, N.R. (2018). Technology preferences to enhance HIV and HCV care among patients with substance use disorders. Journal of Addictive Diseases
37(3-4), pp.157-159.
Tofighi, B., Stein, M., Abrantes, A. (2018). Technology-based interventions for substance use disorders: a review of the literature. Medical Clinics of North America
102(4), 715-731.
Zhang S, Shoptaw S, Reback CJ, Yadav K, Nyamathi A (2018). Cost-Effective Way to Reduce Stimulant Abuse among Gay/Bisexual Men and Transgender Women: A Randomized Clinical Trial with a Cost Comparison Public Health
154: 151-160. PMID: 29245022 PMCID: PMC5745270.
2017
Allen A, Chen D, Bonnie RJ, Koa TM, Surratt CE, Lee JD, Friedmann P, Gordon MS, McDonald R, Murphy S, Boney T, Nunes E, O’Brien CP (2017). Assessing informed consent in an opioid relapse prevention study with adults under current or recent criminal justice supervision Journal of Substance Abuse Treatment
81, 66–72.
Anderson-Carpenter KD, Fletcher JB, Reback CJ (2017). Associations between Methamphetamine Use, Housing Status, and Incarceration Rates among Men Who Have Sex with Men and Transgender Women Journal of Drug Issues
47(3):383-395. doi: 10.1177/0022042617696917. Epub 2017 Mar 9. PMID: 28670005.
Carswell, S.B., Gordon MS, Gryczynski J, and Tangires S (2018). The daily progress system: A proof of concept pilot study of a recovery support technology tool for outpatient substance abuse treatment The American Journal of Drug and Alcohol Abuse
Published online: 30 May 2018.
Chandler R, Gordon MS, Kruszka B, Strand LN, Altice FL, Beckwith CG, Biggs ML, Cunningham W, Chris Delaney JA, Flynn PM, Golin CE, Knight K, Kral AH, Kuo I, Lorvick J, Nance RM, Ouellet LJ, Rich JD, Sacks S, Seal D, Spaulding A, Springer SA, Taxman F, Wohl D, Young JD, Young R, Crane HM (2017). Cohort profile: seek, test, treat and retain United States criminal justice cohort Substance Abuse Treatment, Prevention, and Policy
12(1):24. doi: 10.1186/s13011-017-0107-4. PMID:28511680.
Fletcher JB, Reback CJ (2017). Mental health disorders among homeless, substance-dependent men who have sex with men Drug and Alcohol Review
36(4):555-559. doi: 10.1111/dar.12446. Epub 2016 Aug 12. PMID: 27516073.
Gordon MS (2017). Television interview with Investigative Reporter Barry Sims of WBAL-TV Channel 11. Long-acting naltrexone for prisoners
Gordon MS, Carswell, S.B., Peters EN, Tangires S, Kinlock TW, Vocci FJ, and Restivo L (2017). Avatar assisted therapy: A novel technology-based Intervention to treat substance use disorders In Pam Lassiter (ed.), Annual Review of Addictions and Offender Counseling: Best Practices III
(p 97 - 114). Eugene, OR: Wipf & Stock Publishers.
Gordon MS, Carswell, S.B., Schadegg M, Mangen K, Merkel K, Tangires S, Vocci FJ (2017). Avatar-assisted therapy: a proof-of-concept pilot study of a novel technology-based intervention to treat substance use disorders American Journal of Drug and Alcohol Abuse
43(5):518-524. doi: 10.1080/00952990.2017.1280816.
Gordon MS, Fitzgerald TT (2017). Television interview with Maryland Department of Public Safety Reporter Gerard Shields. Long-acting naltrexone for prisoners
Gordon MS, Kinlock TW, Schwartz RP, O’Grady KE, Fitzgerald TT, Vocci FJ (2017). A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release Drug and Alcohol Dependence
172:34-42. doi: 10.1016/j.drugalcdep.2016.11.037. Epub 2017 Jan 11. PMID: 28107680.
Gordon MS, Vocci FJ, Fitzgerald TT, O’Grady KE, O’Brien CP (2017). Extended-release naltrexone for pre-release prisoners: A randomized trial of medical mobile treatment Contemporary Clinical Trials
53:130-136. doi: 10.1016/j.cct.2016.12.015. PMID:28011389.
Kelly SM, O’Grady KE, Gryczynski J, Mitchell SG, Kirk A, Schwartz RP (2017). The concurrent validity of the Problem Oriented Screening Instrument for Teenagers (POSIT) substance use/abuse subscale in adolescent patients in an urban federally qualified health center Substance Abuse
38(4):382-388. doi: 10.1080/08897077.2017.1351413. Epub 2017 Jul 7. PMID: 28686545.
Kussin-Shoptaw AL, Fletcher JB, Reback CJ (2017). Physical and/or Sexual Abuse Is Associated with Increased Psychological and Emotional Distress Among Transgender Women LGBT Health
4(4):268-274. doi: 10.1089/lgbt.2016.0186. Epub 2017 May 12. PMID: 28498023.
Loeliger KB, Biggs ML, Young R, Seal DW, Beckwith CG, Kuo I, Gordon MS, Altice FL, Ouellet LJ, Cunningham WE, Young JD, Springer SA (2017). Gender Differences in HIV Risk Behaviors Among Persons Involved in the U.S. Criminal Justice System and Living with HIV or at Risk for HIV: A “Seek, Test, Treat, and Retain” Harmonization Consortium AIDS and Behavior. doi
10.1007/s10461-017-1722-9. PMID:28188460.
Nance RM, Delaney JA, Golin CE, Wechsberg WM, Cunningham C, Altice F, Christopoulos K, Knight K, Quan V, Gordon MS, Springer S, Young J, Crane PK, Mayer KH, Mugavero MJ, Del Rio C, Kronmal RA, Crane HM (2017). Co-calibration of two self-reported measures of adherence to antiretroviral therapy AIDS Care
29(4):464-468. doi: 10.1080/09540121.2016.1263721.
Reback CJ, Fletcher JB (2017). Outcomes from a Homegrown HIV Prevention Program for Extremely High-risk, Substance-using Men who have Sex with Men with Multiple Health Disparities Journal of Gay & Lesbian Social Services
DOI: 10.1080/10538720.2017.1296394.
Reback CJ, Rünger D, Fletcher JB (2017). Physical and/or Sexual Abuse Are Associated with Negative Health Outcomes among Transgender Women of Color Living with HIV Violence and Gender
4(4): 130-136. DOI: 10.1089/vio.2017.0042.
Rebchook G, Keatley J, Contreras R, Perloff J, Molano LF, Reback CJ, Ducheny K, Nemoto T, Lin R, Birnbaum J, Woods T, Xavier J; SPNS Transgender Women of Color Study Group (2017). The Transgender Women of Color Initiative: Implementing and Evaluating Innovative Interventions to Enhance Engagement and Retention in HIV Care American Journal of Public Health
107(2):224-229. doi: 10.2105/AJPH.2016.303582. PMID: 28075641.
Rusow JA, Fletcher JB, Reback CJ (2017). Sexual Venue Choice and Sexual Risk-Taking Among Substance-Using Men Who have Sex with Men AIDS and Behavior
21(4):1149-1162. doi: 10.1007/s10461-016-1630-4. PMID: 27905014.
Schwartz RP, Kelly SM, Mitchell SG, Gryczynski J, O’Grady KE, Gandhi D, Olsen Y, Jaffe JH (2017). Patient‐centered methadone treatment: a randomized clinical trial Addiction
112(3):454-64.
Schwartz RP, Kelly SM, Mitchell SG, Gryczynski J, O’Grady KE, Jaffe JH (2017). When does methadone treatment reduce arrest and severity of arrest charges? An analysis of arrest records Drug and Alcohol Dependence
180:385-390. doi: 10.1016/j.drugalcdep.2017.08.025. Epub 2017 Sep 14. PMID: 28961545.
Sharma A., Kelly, S. M., Mitchell, S. G., Gryczynski, J., O’Grady, K. E., & Schwartz, R. P. (2017). Update on Barriers to Pharmacotherapy for Opioid Use Disorders. Current psychiatry reports, 19
(6), 35.
Shoptaw S, Landovitz RJ, Reback CJ (2017). Contingent Vs. Non-Contingent Rewards: Time-Based Intervention Response Patterns Among Stimulant-Using Men Who Have Sex With Men Journal of Substance Abuse Treatment
72:19-24. doi: 10.1016/j.jsat.2016.09.004. Epub 2016 Sep 13. PMID: 27938777.
Sigmon SC, Schwartz RP, Higgins ST (2017). Buprenorphine for Persons on Waiting Lists for Treatment for Opioid Dependence New England Journal of Medicine
376(10):1000-1001. doi: 10.1056/NEJMc1700539. No abstract available. PMID: 28273017.
Stitzer ML, Schwartz RP, Bigelow GE (2017). Prescription opioids: New perspectives and research on their role in chronic pain management and addiction Drug and Alcohol Dependence
173 Suppl 1:S1-S3. doi: 10.1016/j.drugalcdep.2016.11.018. No abstract available. PMID: 28363314.
Wu LT, McNeely J, Subramaniam GA, Brady KT, Sharma G, VanVeldhuisen P, Zhu H, Schwartz RP (2017). DSM-5 substance use disorders among adult primary care patients: Results from a multisite study Drug and Alcohol Dependence
179:42-46. doi: 10.1016/j.drugalcdep.2017.05.048. Epub 2017 Jul 13. PMID: 28753480.
Zaller N, Gordon MS, Bazerman L, Kuo I, Beckwith C (2017). Individuals under community supervision in Baltimore, MD Journal of Correctional Healthcare
23(3), 305-312.
2016
Bruno Genetti, M. A. S., Milena Sperotto, M. A. S., Alessandra Andreotti, M. A. S., Monica Zermiani, M. A. S., Paolo Vian, E. G., Anjalee Sharma A, M.S.W, Robert P. Schwartz, M.D., & Giovanni Serpelloni, M. D. (2016). Prevalence and correlates for alcohol, cigarette, and cannabis use among Italian high School Students: A National Survey.
Chandler RK, Finger MS, Farabee D, Schwartz RP, Condon T, Dunlap LJ, Zarkin GA, McCollister K, McDonald RD, Laska E, Bennett D, Kelly SM, Hillhouse M, Mitchell SG, O’Grady KE, Lee J (2016). The SOMATICS collaborative: Introduction to a National Institute on Drug Abuse cooperative study of pharmacotherapy for opioid treatment in criminal justice settings. Contemporary Clinical Trials
48:166-72. doi: 10.1016/j.cct.2016.05.003. PMID: 27180088.
Fletcher JB, Reback CJ (2016). Mental health disorders among homeless, substance-dependent men who have sex with men Drug and Alcohol Review
doi: 10.1111/dar.12446.
Glasner-Edwards S, Patrick K, Ybarra ML, Reback CJ, Rawson RA, Garneau HC, Chavez Kand Venegas A (2016). A Cognitive Behavioral Therapy Based Text Messaging Intervention Versus Medical Management for HIV-Infected Substance Users Journal of Medical Internet Research, Research Protocols
5(2).
Gordon MS, Carswell, S.B., Wilson M, Kinlock TW, Restivo LL, McKenzie M, Rich JD, (2016). Factors Associated With Receiving Rapid HIV Testing Among Individuals on Probation or Parole Journal of Correctional Health Care
22(4):290-299. PMID: 27742854.
Gryczynski J, O’Grady KE, Mitchell SG, Ondersma SJ, Schwartz RP (2016). Immediate Versus Delayed Computerized Brief Intervention for Illicit Drug Misuse Journal of Addiction Medicine
10(5):344-51. doi: 10.1097/ADM.0000000000000248. PMID: 27504925.
Gryczynski J, Schwartz RP, O’Grady KE, Restivo LL, Mitchell SG, Jaffe JH (2016). Understanding patterns of high-cost health care use across different substance user groups Health Affairs
(Millwood). 35(1):12-9. doi: 10.1377/hlthaff.2015.0618. PMID: 26733696 PMCID: PMC4936480 DOI: 10.1377/hlthaff.2015.0618.
Hong YA, Mitchell SG, Peterson JA, Latkin C, Tobin K (2016). Ethnographic process evaluation. Monitoring and Evaluation in Health and Social Development: Interpretive and Ethnographic Perspectives
159.
Hunter SB, Schwartz RP, Friedmann PD (2016). Introduction to the Special Issue on the Studies on the Implementation of Integrated Models of Alcohol, Tobacco, and/or Drug Use Interventions and Medical Care. Journal of Substance Abuse Treatment
60:1-5. doi: 10.1016/j.jsat.2015.10.001. Epub 2015 Oct 20. PMID: 26549295.
Kelly SM, Gryczynski J, Mitchell SG, Kirk A, O’Grady KE, Schwartz RP (2016). Corrigendum to "Concordance between DSM-5 and DSM-IV nicotine, alcohol, and cannabis use disorder diagnoses among pediatric patients" [Drug Alcohol Depend. 140 (2014) 213-216]. Drug and Alcohol Dependence
168:203. doi: 10.1016/j.drugalcdep.2016.09.012. PMID: 27697697.
Kinlock TW, and Gordon MS (2016). Heroin and Other Opiates. In Henry H. Brownstein (ed.) The Handbook of Drugs and Society
(pp. 72-89). West Sussex, UK: John Wiley & Sons, Inc.
Mitchell SG, Schwartz RP, Kirk AS, Dušek K, Oros M, Hosler C, Gryczynski J, Barbosa C, Dunlap L, Lounsbury D, O’Grady KE, Brown BS (2016). SBIRT Implementation for Adolescents in Urban Federally Qualified Health Centers. Journal of Substance Abuse Treatment.
60:81-90. doi:10.1016/j.jsat.2015.06.011. Epub 2015 Jun 26. PMID: 26297321.
Mitchell SG, Willett J, Monico LB, James A, Rudes DS, Viglioni J, Schwartz RP, Gordon MS, Friedmann PD (2016). Community Correctional Agents’ Views of Medication-Assisted Treatment: Examining their Influence on Treatment Referrals and Community Supervision Practices. Substance Abuse
37(1):127-33. doi: 10.1080/08897077.2015.1129389. PMID: 26860334. PMCID: PMC4823810.
Monico LB, Mitchell SG, Welsh W, Link N, Hamilton L, Malvini Redden S, Schwartz RP, Friedmann PD (2016). Developing effective interorganizational relationships between community corrections and community treatment providers. Journal of Offender Rehabilitation
55(7):484-501.
Monico LB, Schwartz RP, Gryczynski J, O’Grady KE, Mitchell SG (2016). Two models of integrating buprenorphine treatment and medical staff within formerly "drug-free" outpatient programs. Journal of Psychoactive Drugs
48(2):101-8. doi: 10.1080/02791072.2015.1130884. PMID: 26940870.
O’Grady KE, Gryczynski J, Mitchell SG, Ondersma SJ, Schwartz RP (2016). Confirmatory factor analysis of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in community health center patients. American Journal on Addictions
25(4):259-63. doi: 10.1111/ajad.12360. PMID: 27037633.
Ondersma SJ, Gryczynski J, Mitchell SG, O’Grady KE, Schwartz RP (2016). Process evaluation of a technology-delivered screening and brief intervention for substance use in primary care. Internet Interventions.
4(Pt 1):11-16. PMID: 27110494PMCID: PMC4836054. DOI: 10.1016/j.invent.2016.01.004.
Pines HA, Gorbach PM, Weiss RE, Reback CJ, Landovitz RJ, Mutchler MG, Mitsuyasu RT (2016). Individual-Level, Partnership-Level, and Sexual Event-Level Predictors of Condom Use During Receptive Anal Intercourse Among HIV-Negative Men Who Have Sex with Men in Los Angeles. AIDS and Behavior
20(6), 1315-1326.
Reback CJ, Kaplan RL, Bettcher TM, Larkins S (2016). The role of the illusion in the construction of erotic desire: narratives from heterosexual men who have occasional sex with transgender women Culture, Health & Sexuality
18(8), 951-963.
Rosenthal RN, Lofwall MR, Kim S, Chen M, Beebe KL, Vocci FJ (2016). Effect of buprenorphine implants on illicit opioid use among abstinent adults with opioid dependence treated with sublingual buprenorphine: A randomized clinical trial. Journal of the American Medical Association
316(3), 282-290.
Rusow JA, Fletcher JB, Reback CJ (2016). Sexual Venue Choice and Sexual Risk-Taking Among Substance-Using Men Who have Sex with Men. AIDS and Behavior
1-14.
Schwartz RP (2016). When Added to Opioid Agonist Treatment, Psychosocial Interventions do not Further Reduce the Use of Illicit Opioids: A Comment on Dugosh et al. Journal of Addiction Medicine
10(4):283-5. doi: 10.1097/ADM.0000000000000236. PMID: 27471920.
Schwartz RP, Kelly SM, Mitchell SG, Gryczynski J, O’Grady KE, Gandhi D, Olsen Y, Jaffe JH (2016). Patient-centered methadone treatment: a randomized clinical trial. Addiction
doi: 10.1111/add.13622. [Epub ahead of print]. PMID: 27661788.
Schwartz, R. P., Kelly, S. M., Mitchell, S. G., Dunlap, L., Zarkin, G. A., Sharma A., O’Grady, K.E., & Jaffe, J. H. (2016). Corrigendum to “Interim methadone and patient navigation in jail: Rationale and design of a randomized clinical trial.”[Contemp. Clin. Trials 49 (2016): 21–28]. Contemporary clinical trials, 51
, 97.
Schwartz, R. P., Kelly, S. M., Mitchell, S. G., Dunlap, L., Zarkin, G. A., Sharma A., O’Grady, K.E., & Jaffe, J. H. (2016). Interim methadone and patient navigation in jail: Rationale and design of a randomized clinical trial. Contemporary Clinical Trials.
Sharma A., O’Grady, K. E., Kelly, S. M., Gryczynski, J., Mitchell, S. G., & Schwartz, R. P. (2016). Pharmacotherapy for opioid dependence in jails and prisons: research review update and future directions. Substance abuse and rehabilitation, 7
, 27.
Sigmon SC, Ochalek TA, Meyer AC, Hruska B, Heil SH, Badger GJ, Rose G, Brooklyn JR, Schwartz RP, Moore BA, Higgins ST (2016). Interim Buprenorphine vs. Waiting List for Opioid Dependence. New England Journal of Medicine
375(25):2504-2505. doi: 10.1056/NEJMc1610047. PMID: 28002704. DOI: 10.1056/NEJMc1610047.
Wu LT, McNeely J, Subramaniam G, Sharma G, VanVelduisen P, Schwartz RP (2016). Design of the NIDA Clinical Trials Network Validation Study of Tobacco, Alcohol, Prescription Medications, and Substance Use/Misuse (TAPS) Tool. Contemporary Clinical Trials
50:90-7. doi: 10.1016/j.cct.2016.07.013. PMID: 27444426.
Wu LT, McNeely J, Subramaniam GA, Sharma G, VanVeldhuisen P, Schwartz RP (2016). Corrigendum to "Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool" [Contemporary Clinical Trials. 19; 50: 90-97]. Contemporary Clinical Trials
51:98. doi: 10.1016/j.cct.2016.09.001. PMID: 27665683.
2015
Barbosa C, Dunlap LJ, Wedehase B, Mitchell SG, Schwartz RP, Dušek K, Kirk AS, Oros M, Hosler C, Gryczynski J, Brown BS (2015). Start-up costs of implementing Screening and Brief Intervention (SBI) for Adolescents (part of Economics of SBI symposium) Addiction Science and Clinical Practice
10 (Suppl 2), O5.
Fletcher JB, Reback CJ (2015). Depression Mediates and Moderates Effects of Methamphetamine Use on Sexual Risk Taking Among Treatment-Seeking Gay and Bisexual Men. Health Psychology
34(8):865-9. doi: 10.1037/hea0000207. Epub 2015 Jan 12. PMID: 25581704.
Gordon MS, Kinlock TW, Schwartz RP, Couvillion KA, Sudec LJ, O’Grady KE, Vocci FJ, Shabazz H (2015). Buprenorphine Treatment for Probationers and Parolees Substance Abuse
36(2):217-25. doi: 10.1080/08897077.2014.902787. Epub 2014 Apr 4. PMID: 24701967.
Gordon MS, Kinlock TW, Vocci FJ, Fitzgerald TT, Memisoglu A, Silverman B (2015). A Phase 4, Pilot, Open-Label Study of VIVITROL® (Extended-Release Naltrexone XR-NTX) for Prisoners Journal of Substance Abuse Treatment
59:52-8. doi: 10.1016/j.jsat.2015.07.005. Epub 2015 Jul 18. PMID: 26299956.
Gryczynski J, Kelly SM, Mitchell SG, Kirk A, O’Grady KE, Schwartz RP (2015). Validation and performance of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) among adolescent primary care patients Addiction.
110(2):240-7. doi: 10.1111/add.12767. Epub 2014 Nov 20. PMID: 25311148.
Gryczynski J, Mitchell SG, Gonzales A, Moseley A, Peterson TR, Ondersma SJ, O’Grady KE, Schwartz RP (2015). A randomized trial of computerized vs. in-person brief intervention for illicit drug use in primary care: outcomes through 12 months. Journal of Substance Abuse Treatment
50, 3-10. doi: 10.1016/j.jsat.2014.09.002. Epub 2014 Sep 16. PMID: 25282578.
Gryczynski J, Mitchell SG, Jaffe JH, O’Grady KE, Olsen YK, Schwartz RP (2015). Leaving buprenorphine treatment: patients’ reasons for cessation of care Journal of Substance Abuse Treatment
46(3):356-61. PubMed PMID: 24238714; PubMed Central PMCID: PMC3947058.
Gryczynski J, Mitchell SG, Ondersma SJ, O’Grady KE, Schwartz RP (2015). Potential radiating effects of misusing substances among medical patients receiving brief intervention Journal of Substance Abuse Treatment
55:39-44.
Gryczynski J, Schwartz RP, Mitchell SG, Dzirasa L, Dušek K, O’Grady K, and Cowell A (2015). Preliminary research in preparation for a randomized trial of brief intervention strategies for adolescents in school-based health centers Addiction Science and Clinical Practice
10 (Suppl 2), O20. http://doi.org/10.1186/1940-0640-10-S2-O20.
Hall TM, Reback CJ, Shoptaw S (2015). Clinical Management of Substance Use and Substance Use Disorders among LGBT Individuals. In H.J. Makadon, K.H. Mayer, J. Potter, & H. Goldhammer (Eds.), The Fenway Guide to Lesbian, Gay, Bisexual, and Transgender Health
2nd Edition. Philadelphia: American College of Physicians Books, pp. 227-267.
Kinlock TW and Gordon MS (2015). Pharmacotherapy for Incarcerated Individuals with Histories of Heroin Addiction. In Ayman M. Fareed (ed.), Heroin Addiction: Prevalence, Treatment Approaches and Health Consequences
(pp. 127-142). Hauppauge, NY: Nova Science Publishers, Inc.
Landovitz RJ, Fletcher JB, Shoptaw S, Reback CJ (2015). Contingency management facilitates the use of postexposure prophylaxis among stimulant-using men who have sex with men. Open Forum Infectious Diseases
1;2(1):ofu114. doi: 10.1093/ofid/ofu114. eCollection 2015 Jan. PMID: 25884003. PMCID: PMC4396429.
Lee JD, Friedmann PD, Boney TY, Hoskinson RA Jr, McDonald R, Gordon MS, Fishman M, Chen DT, Bonnie RJ, Kinlock TW, Nunes EV, Cornish JW, O’Brien CP (2015). Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: rationale and design of a randomized controlled effectiveness trial Contemporary Clinical Trials
41:110-7.
Mitchell SG, Gryczynski J, Schwartz RP, Myers CP, O’Grady KE, Olsen YK, Jaffe JH (2015). Changes in Quality of Life following Buprenorphine Treatment: Relationship with Treatment Retention and Illicit Opioid Use. Journal of Psychoactive Drugs
47(2):149-57.
Mitchell SG, Monico LB, Gryczynski J, O’Grady KE, Schwartz RP (2015). Staff Views of Acceptability and Appropriateness of a Computer-Delivered Brief Intervention for Moderate Drug and Alcohol Use. Journal of Psychoactive Drugs
47(4):301-7. doi: 10.1080/02791072.2015.1075631. Epub 2015 Sep 16. PMID: 26375411.
Mitchell SG, Schwartz RP, Alvanzo AA, Weisman MS, Kyle TL, Turrigiano EM, Gibson ML, Perez L, McClure EA, Clingerman S, Froias A, Shandera DR, Walker R, Babcock DL, Bailey GL, Miele GM, Kunkel LE, Norton M, Stitzer ML (2015). The Use of Technology in Participant Tracking and Study Retention: Lessons Learned from a Clinical Trials Network Study. Substance Abuse
36(4):420-6. doi: 10.1080/08897077.2014.992565. Epub 2015 Feb 11. PMID: 25671593. PMCID: PMC4532645.
Mitchell SG, Willett J, Swan H, Monico LB, Yang Y, Patterson Y, Belenko S, Vega-Debien Graciela Pankow J, Schwartz RP and Visher C (2015). Defining success: Insights from a random assignment, multi-site study of implementing HIV prevention, testing and linkage to care in US jails and prisons. AIDS Education and Prevention
27(5):432-45. doi: 10.1521/aeap.2015.27.5.432. PMID: 26485233.
Monico LB, Abdel-Salam S, O’Connell D, Visher C, Martin S (2015). Using Organizational Strategies to Improve Substance Abuse Treatment for Probationers: A Case Study in Delaware Federal Probation
Dec 2015.
Monico LB, Gryczynski J, Mitchell SG, Schwartz RP, O’Grady KE, Jaffe JH (2015). Buprenorphine treatment and 12-step meeting attendance: conflicts, compatibilities, and patient outcomes. Journal of Substance Abuse Treatment
57:89-95. doi: 10.1016/j.jsat.2015.05.005. Epub 2015 May 12. PMID: 25986647.
Monico LB, Mitchell SG, Gryczynski J, Schwartz RP, O’Grady KE, Olsen YK, Jaffe JH (2015). Prior experience with non-prescribed buprenorphine: Role in treatment entry and retention. Journal of Substance Abuse Treatment
57:57-62. doi: 10.1016/j.jsat.2015.04.010. Epub 2015 May 7. PMID: 25980599.
Nyamathi A, Reback CJ, Salem BE, Zhang S, Shoptaw S, Branson CM, Leake B (2015). Correlates of self-reported incarceration among homeless gay and bisexual stimulant-using young adults Western Journal of Nursing Research
37(6):799-811. doi: 10.1177/0193945914530521. Epub 2014 Apr 14. PMID: 24733231.
Peters EN, Harrell PT, Hendricks PS, O’Grady KE, Pickworth WB, Vocci FJ (2015). Electronic cigarettes in adults in outpatient substance use treatment: Awareness, perceptions, use, and reasons for use American Journal on Addictions.
24(3):233-9.
Reback CJ, Fletcher JB, Shoptaw S, Mansergh G (2015). Exposure to Theory-Driven Text Messages is Associated with HIV Risk Reduction Among Methamphetamine-Using Men Who have Sex with Men. AIDS and Behavior
19 Suppl 2:130-41. doi: 10.1007/s10461-014-0985-7. PMID: 25563501.
Reback CJ, Kaplan RL, Larkins S (2015). Disclosure of Male Sexual Partnering and HIV Serostatus Among a Sample of Heterosexually Identified Men Who Have Sex With Men and Women AIDS Education and Prevention
27(3):227-39. doi: 10.1521/aeap.2015.27.3.227. PMID: 26010314.
Salem B, Nyamathi A, Reback CJ (2015). Unmet Physical and Mental Healthcare Needs among Stimulant-using Gay and Bisexual Homeless Men. Issues in Mental Health Nursing
36: 685-692. DOI: 10.3109/01612840.2015.1021938.
Schwartz RP, Kelly SM, Gryczynski J, Mitchell SG, O’Grady KE, Jaffe JH (2015). Heroin use, HIV-risk, and criminal behavior in Baltimore: Findings from Clinical Research. Journal of Addictive Diseases
34(2-3):151-61. doi: 10.1080/10550887.2015.1059222. PMID: 26079104.
Sigmon SC, Meyer AC, Hruska B, Ochalek T, Rose G, Badger GJ, Brooklyn JR, Heil SH, Higgins ST, Moore BA, Schwartz RP (2015). Bridging waitlist delays with Interim Buprenorphine Treatment: Initial feasibility. Addictive Behaviors
51:136-142.
Visher CA, Yang Y, Mitchell SG, Patterson Y, Swan H, Pankow J (2015). Understanding the Sustainability of Implementing HIV Services in Criminal Justice Settings Health & Justice
3(5).
Vocci FJ, Schwartz RP, Wilson ME, Gordon MS, Kinlock TW, Fitzgerald TT, O’Grady KE, Jaffe JH (2015). Buprenorphine dose induction in non-opioid-tolerant pre-release prisoners. Drug and Alcohol Dependence
156:133-8. doi: 10.1016/j.drugalcdep.2015.09.001. Epub 2015 Sep 7. PMID: 26409751.
Welsh W, Prendergast M, Knight K, Knudsen H, Monico LB, Gray J, Abdel-Salam S, Malvini Redden S, Link N, Hamilton L, Shafer MS, Friedmann P (2015). Correlates of interorganizational service coordination in community corrections Criminal Justice and Behavior
43(4):483-505.
Welsh WN, Knudsen HK, Knight K, Ducharme L, Pankow J, Urbine T, Lindsey A, Abdel-Salam S, Wood J, Monico LB, Link N, Albizu-Garcia C, Friedmann PD (2015). Effects of an organizational linkage intervention on interorganizational service coordination between probation/parole agencies and community treatment providers Administration and Policy in Mental Health Journal
43(1):105-21.
Welsh WN, Lin H, Peters RH, Stahler GJ, Lehman WEK, Stein LAR, Monico LB, Eggers M, Abdel-Salam S, Pierce JC, Hunt E, Gallagher C, Frisman LK (2015). Effects of a strategy to improve offender assessment practices: Staff perceptions of implementation outcomes Drug and Alcohol Dependence
152:230-238.
2014
Bellamoli E, Manganotti P, Schwartz RP, Rimondo C, Gomma M, Serpelloni G (2014). rTMS in the treatment of drug addiction: an update about human studies. Behavioural Neurology
2014:815215. PubMed PMID: 24803733; PubMed Central PMCID: PMC4006612.
Burruss, K., Sacco, P., & Smith, C.A (2014). Understanding older adults’ attitudes and beliefs about drinking: Perspectives of residents in congregate living. Ageing & Society.
doi:10.1017/SO144686X14000671.
Carswell, S.B., Hanlon TE, O’Grady KE, Watts AM (2014). Correlates of risky sexual activity for urban African American youth in an alternative education program Education and Urban Society
46(4), 434-449. doi:10.1177/0013124512458119.
Carswell, S.B., Hanlon TE, Watts A, O’Grady KE (2014). Prevention-related research targeting African American alternative education program students. Education and Treatment of Children
46(4), 434-449. doi:10.1177/0013124512458119.
Fletcher JB, Dierst-Davies R, Reback CJ (2014). Contingency management voucher redemption as an indicator of delayed gratification Journal of Substance Abuse Treatment
47(1):73-7. doi: 10.1016/j.jsat.2014.03.003. Epub 2014 Mar 12.PMID:24674235.
Fletcher JB, Shoptaw S, Peck JA, Reback CJ (2014). Contingency Management Reduces Symptoms of Psychological and Emotional Distress among Homeless, Substance-dependent Men Who Have Sex with Men Mental Health and Substance Use
7(4):420-430.PMID:25364379.
Gordon MS, Kinlock TW, Schwartz RP, Fitzgerald TT, O’Grady KE, Vocci FJ (2014). A randomized controlled trial of prison-initiated buprenorphine: prison outcomes and community treatment entry Drug and Alcohol Dependence
142, 33-40. doi: 10.1016/j.drugalcdep.2014.05.011. Epub 2014 Jun 2. PMID: 24962326.
Holtyn AF, Koffarnus MN, DeFulio A, Sigurdsson SO, Strain EC, Schwartz RP, Leoutsakos JM, Silverman K (2014). The therapeutic workplace to promote treatment engagement and drug abstinence in out-of-treatment injection drug users: a randomized controlled trial Preventative Medicine
68:62-70. Epub 2014 Mar 4.PMID: 24607365.
Holtyn AF, Koffarnus MN, DeFulio A, Sigurdsson SO, Strain EC, Schwartz RP, Silverman K (2014). Employment-based abstinence reinforcement promotes opiate and cocaine abstinence in out-of-treatment injection drug users Journal of Applied Behavior Analysis
47(4):681-93. doi: 10.1002/jaba.158. Epub 2014 Oct 8. PMID: 25292399.
Kelly SM, Gryczynski J, Mitchell SG, Kirk A, O’Grady KE, Schwartz RP (2014). Concordance between DSM-5 and DSM-IV nicotine, alcohol, and cannabis use disorder diagnoses among pediatric patients. Drug and Alcohol Dependence
140:213-6. PubMed PMID: 24793367; PubMed Central PMCID: PMC4070874.
Kelly SM, Gryczynski J, Mitchell SG, Kirk A, O’Grady KE, Schwartz RP (2014). Validity of brief screening instrument for adolescent tobacco, alcohol, and drug use. Pediatrics
133(5):819-26. PubMed PMID: 24753528; PubMed Central PMCID: PMC4006430.
Mitchell SG, Gryczynski J, Kelly SM, O’Grady KE, Jaffe JH, Olsen YK, Schwartz RP (2014). Treatment Outcomes of African American Buprenorphine Patients by Parole and Probation Status Journal of Drug Issues
44(1):69-82. PMID:25364037.
Müller-Leonhardt A, Mitchell SG, Vogt J, Schürmann T (2014). Critical Incident Stress Management (CISM) in complex systems: cultural adaptation and safety impacts in healthcare Accident Analysis and Prevention
68:172-80. PubMed PMID: 24491831.
Paterson NE, Vocci F, Sevak RJ, Wagreich E, London ED (2014). Dopamine D3 receptors as a therapeutic target for methamphetamine dependence. American Journal of Drug and Alcohol Abuse
40(1):1-9. PubMed PMID: 24359505.
Peters EN, Hendricks PS, Clark CB, Vocci FJ, Cropsey KL (2014). Association of race and age with treatment attendance and completion among adult marijuana users in community-based substance abuse treatment. Journal of Addiction Medicine
8(2):143-9. PubMed PMID: 24603621.
Peters EN, Schwartz RP, Wang S, O’Grady KE, Blanco C (2014). Psychiatric, psychosocial, and physical health correlates of co-occurring cannabis use disorders and nicotine dependence. Drug and Alcohol Dependence
134:228-34. PubMed PMID: 24183498; PubMed Central PMCID: PMC3865597.
Reback CJ, Fletcher JB (2014). HIV prevalence, substance use, and sexual risk behaviors among transgender women recruited through outreach AIDS and Behavior
18(7):1359-67. doi: 10.1007/s10461-013-0657-z.PMID:24287786.
Reback CJ, Fletcher JB (2014). Reductions in HIV prevalence rates among substance-using men who have sex with men in Los Angeles County, 2008-2011. AIDS Education and Prevention
26(5):459-70.doi: 10.1521/aeap.2014.26.5.459.PMID:25299809.
Reback CJ, Shoptaw S (2014). Development of an evidence-based, gay-specific cognitive behavioral therapy intervention for methamphetamine-abusing gay and bisexual men Addictive Behaviors
39(8):1286-91. doi: 10.1016/j.addbeh.2011.11.029. Epub 2011 Nov 26PMID:22169619.
Reback CJ, Veniegas R, Shoptaw S (2014). Getting Off: development of a model program for gay and bisexual male methamphetamine users Journal of Homosexuality
61(4):540-53. doi: 10.1080/00918369.2014.865459.PMID:24245506.
Rusow JA, Fletcher JB, Le H, Reback CJ (2014). Sexual Abuse is Associated with Negative Health Consequences among High-risk Men who have Sex with Men Journal of Gay & Lesbian Social Services
26(2):244-257.PMID:25505831.
Sacco, P., Burruss, K., Smith, C., Kuerbis, A., Harrington, D., Moore, A.A., & Resnick, B. (2014). Drinking behavior among older adults at a continuing care retirement community: Affective and motivational influences. Aging & Mental Health.
doi:10.1080/13607863.2014.933307.
Schwartz RP, Alexandre PK, Kelly SM, O’Grady KE, Gryczynski J, Jaffe JH (2014). Interim versus standard methadone treatment: a benefit-cost analysis. Journal of Substance Abuse Treatment
46(3):306-14. doi: 10.1016/j.jsat.2013.10.003. Epub 2013 Oct 14.PMID:24239030.
Teruya C, Schwartz RP, Mitchell SG, Hasson AL, Thomas C, Buoncristiani SH, Hser Y-I, Wiest K, Cohen AJ, Glick N, Jacobs P, McLaughlin P, Ling W (2014). Patient perspectives on buprenorphine/naloxone: A qualitative study of retention during the Starting Treatment with Agonist Replacement Therapies (START) study Journal of Psychoactive Drugs
46(5):412-26. doi: 10.1080/02791072.2014.921743. PMID: 25364994.
2013
Blanco C, Iza M, Schwartz RP, Rafful C, Wang S, Olfson M (2013). Probability and predictors of treatment-seeking for prescription opioid use disorders: a national study. Drug and Alcohol Dependence
131 (1-2), 143-148.
Blanco C, Rafful C, Wall MW, Jin CJ, Kerridge B, Schwartz RP (2013). The latent structure and predictors of non-medical prescription drug use and prescription drug use disorders: a national study. Drug and Alcohol Dependence
133(2), 473-479.
Defulio A, Stitzer M, Roll J, Petry N, Nuzzo P, Schwartz RP, et al (2013). Criminal justice referral and incentives in outpatient substance abuse treatment. Journal of Substance Abuse Treatment
45. (1), 70-75.
Fletcher JB, Reback CJ (2013). Antisocial personality disorder predicts methamphetamine treatment outcomes in homeless, substance-dependent men who have sex with men. Journal of Substance Abuse Treatment
45(3):266-72.
Friedmann PD, Ducharme LJ, Welsh W, Frisman L, Knight K, Kinlock T, Mitchell SG, Hall E, Urbine T, Gordon MS, Abdel-Salam S, O’Connell D, Albizu-Garcia C, Knudsen H, Duval J, Fenster J; Jennifer Pankow for the CJ-DATS MATICCE Workgroup (2013). A cluster randomized trial of an organizational linkage intervention for offenders with substance use disorders: study protocol Health Justice
19; 1(6). doi: 10.1186/2194-7899-1-6. PMID: 25309847. PMCID: PMC4193542.
Gordon MS, Kinlock TW, Couvillion KA, Schwartz RP, Wilson ME, O’Grady KE (2013). Gender differences among prisoners with pre-incarceration heroin dependence participating in a randomized clinical trial of buprenorphine treatment. Journal of Offender Rehabilitation
52(5), 376-391.
Gordon MS, Kinlock TW, McKenzie M, Rich JD, Wilson ME (2013). Rapid HIV testing for individuals on probation/parole: Outcomes of an intervention trial. AIDS and Behavior
17(6), 2022-2030.
Gordon MS, Kinlock TW, Schwartz RP, Couvillion KA, O’Grady KE (2013). The Severity, Frequency, and Variety of Crime in Heroin-Dependent Prisoners Enrolled in a Buprenorphine Clinical Trial Prison Journal
93(4):390-410.
Gryczynski J, Jaffe JH, Schwartz RP, Dušek KA, Gugsa N, Monroe CL, O’Grady KE, Olsen YK, Mitchell SG (2013). Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system. American Journal on Addictions
22(3):285-91.
Gryczynski J, Mitchell SG, Jaffe JH, Kelly SM, Myers CP, O’Grady KE, Olsen YK, Schwartz RP (2013). Retention in methadone and buprenorphine treatment among African Americans. Journal of Substance Abuse Treatment
45(3):287-92.
Heinz AJ, Peters EN, Boden MT, Bonn-Miller MO (2013). A comprehensive examination of delay discounting in a clinical sample of cannabis-dependent military veterans making a self-guided quit attempt. Experimental and Clinical Psychopharmacology, 21
55-65.
Kelly SM, O’Grady KE, Jaffe JH, Gandhi D, Schwartz RP (2013). Improvements in outcomes in methadone patients on probation/parole regardless of counseling early in treatment Journal of Addiction Medicine
7 (2), 133-138.
Kinlock TW, Gordon MS, Schwartz RP, O’Grady KE (2013). Individual Patient and Program Factors Related to Prison and Community Treatment Completion in Prison-Initiated Methadone Maintenance Treatment. Journal of Offender Rehabilitation
52(8):509-528.
Landovitz RJ, Tseng CH, Weissman M, Haymer M, Mendenhall B, Rogers K, Veniegas R, Gorbach PM, Reback CJ, Shoptaw S (2013). Epidemiology, sexual risk behavior, and HIV prevention practices of men who have sex with men using GRINDR in Los Angeles, California. Journal of Urban Health
90(4):729-39.
Ling Murtaugh K, Krishnamurti T, Davis AL, Reback CJ, Shoptaw S (2013). Spend today, clean tomorrow: predicting methamphetamine abstinence in a randomized controlled trial. Health Psychology
32(9):958-66.
Mitchell SG, Gryczynski J, O’Grady KE, Schwartz RP (2013). SBIRT for adolescent drug and alcohol use: current status and future directions Journal of Substance Abuse Treatment
44 (5), 463-472.
Mitchell SG, Gryczynski J, Schwartz RP, O’Grady KE, Olsen YK, Jaffe JH (2013). A randomized trial of intensive outpatient (IOP) vs. standard outpatient (OP) buprenorphine treatment for African Americans Drug and Alcohol Dependence
128 (3), 222-229.
Peters EN, Petry NM, Lapaglia DM, Reynolds B, Carroll KM (2013). Delay discounting in adults receiving treatment for marijuana dependence Experimental and Clinical Psychopharmacology
21 (1), 46-54.
Reback CJ, Fletcher JB, Shoptaw S, Grella CE (2013). Methamphetamine and other substance use trends among street-recruited men who have sex with men, from 2008 to 2011 Drug and Alcohol Dependence
133 (1), 262-265.
Reback CJ, Larkins S (2013). HIV risk behaviors among a sample of heterosexually identified men who occasionally have sex with another male and/or a transwoman. Journal of Sex Research
50. (2), 151-163.
Rosenthal RN, Ling W, Casadonte P, Vocci F, Bailey GL, Kampman K, Patkar A, Chavoustie S, Blasey C, Sigmon S, Beebe KL (2013). Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone Addiction
108(12):2141-9. doi: 10.1111/add.12315. Epub 2013 Sep 18. PMID: 23919595.
Schwartz RP, Gryczynski J, O’Grady KE, Sharfstein JM, Warren G, Olsen Y, Mitchell SG, Jaffe JH (2013). Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009 American Journal of Public Health
103(5):917-22.
Schwartz RP, Gryczynski J, O’Grady KE, Sharfstein JM, Warren G, Olsen YK, Mitchell SG, Jaffe JH (2013). Schwartz et al. respond. American Journal of Public Health
2013 103(8):e2-3..Epub 2013 Jun 13.
Schwartz RP, Stitzer ML, Feaster DJ, Korthuis PT, Alvanzo AA, Winhusen TM, et al (2013). HIV rapid testing in drug treatment: comparison across treatment modalities. Journal of Substance Abuse Treatment
44. (4), 369-374.
Serpelloni G, Gomma M, Genetti B, Zermiani M, Rimondo C, Mollica R, Gryczynski J, O’Grady KE, Schwartz RP (2013). Italy’s electronic health record system for opioid agonist treatment Journal of Substance Abuse Treatment
45(2):190-5.
2012
Bowers JR, Branson CM, Fletcher JB, Reback CJ (2012). Predictors of HIV sexual risk behavior among men who have sex with men, men who have sex with men and women, and transgender women International Journal of Sexual Health
24 (4), 290-302.
Caldwell D, Gryczynski J (2012). Computerized assessment facilitates disclosure of sensitive HIV risk behaviors among African Americans entering substance abuse treatment American Journal of Drug and Alcohol Abuse
38 (4), 365-369.
Carroll KM, Nich C, Lapaglia DM, Peters EN, Easton CJ, Petry NM (2012). Combining cognitive behavioral therapy and contingency management to enhance their effects in treating cannabis dependence: less can be more, more or less Addiction
107 (9), 1650-1659.
Coviello DM, Cornish JW, Lynch KG, Boney TY, Clark CA, Lee JD, Friedmann PDNunes EV, Kinlock TW, Gordon MS, Schwartz RP, Nuwayser ES, O’Brien CP (2012). A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers Substance Abuse
33 (1), 48-59. [PMCID: PMC3365863].
Friedmann PD, Hoskinson R, Gordon MS, Schwartz R, Kinlock T, Knight K, Flynn PM, Welsh WN, Stein LA, Sacks S, O’Connell DJ, Knudsen HK, Shafer MS, Hall E, Frisman LK (2012). Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions Substance Abuse
33 (1), 9-18. [PMCID: PMC3295578].
Friedmann PD, Schwartz RP (2012). Just call it "treatment". Addiction Science and Clinical Practice 7
(1), 10.
Gonzales A, Westerberg VS, Peterson TR, Moseley A, Gryczynski J, Mitchell SG, Buff G, Schwartz RP (2012). Implementing a statewide Screening, Brief Intervention, and Referral to Treatment (SBIRT) service in rural health settings: New Mexico SBIRT Substance Abuse
33 (2), 114-123. [PMCID: PMC3325793].
Gordon MS, Kinlock TW, Couvillion K, Schwartz RP, O’Grady KE (2012). A randomized clinical trial of methadone maintenance for prisoners: Prediction of treatment entry and completion in prison Journal of Offender Rehabilitation
51 (4), 222-238.
Gryczynski J, Kinlock TW, Kelly SM, O’Grady KE, Gordon MS, Schwartz RP (2012). Opioid agonist maintenance for probationers: Patient-level predictors of treatment retention, drug use, and crime Substance Abuse
33 (1), 30-39.
Gryczynski J, Ward BW (2012). Religiosity, heavy alcohol use, and vicarious learning networks among adolescents in the United States Health Education and Behavior
39 (3), 341-351.
Kelly SM, Brown BS, Katz EC, O’Grady KE, Mitchell SG, King S, Schwartz RP (2012). A comparison of attitudes toward opioid agonist treatment among short-term buprenorphine patients The American Journal of Drug and Alcohol Abuse
38 (3), 233-238.
Kelly SM, Schwartz RP, O’Grady KE, Gandhi D, Jaffe JH (2012). Impact of methadone with versus without drug abuse counseling on HIV risk: 4- and 12-month findings from a clinical trial Journal of Addiction Medicine
6 (2), 145-152. [PMCID: PMC3322294].
Landovitz RJ, Fletcher JB, Inzhakova G, Lake JE, Shoptaw S, Reback CJ (2012). A novel combination HIV prevention strategy: Post-exposure prophylaxis with contingency management for substance abuse treatment among methamphetamine-using men who have sex with men AIDS Patient Care and STDs
26 (6), 320-328.
Mitchell SG, Gryczynski J, Peterson T, Gonzales A, Moseley A, Schwartz RP (2012). Screening, Brief Intervention, and Referral to Treatment (SBIRT) for substance use in a school-based program: Services and outcomes American Journal on Addictions
21 S5-S13.
Mitchell SG, Kelly SM, Brown BS, O’Grady KE, Schwartz RP (2012). HIV sex-risk behaviors among in- versus out-of-treatment heroin-addicted adults American Journal of Drug and Alcohol Abuse
38 (4), 328-333.
Mitchell SG, Kelly SM, Gryczynski J, Myers CP, Jaffe JH, O’Grady KE, Olson YK, Schwartz RP (2012). African-American patients seeking treatment in the public sector: Characteristics of buprenorphine v. methadone patients Drug and Alcohol Dependence
122, 55-60. [PMCID: PMC3251709].
Peters EN, Budney AJ, Carroll KM (2012). Clinical correlates of co-occurring cannabis and tobacco use: a systematic review Addiction
107 (8), 1404-1417.
Peters EN, Leeman RF, Fucito LM, Toll BA, Corbin WR, O’Malley SS (2012). Co-occurring marijuana use is associated with medication nonadherence and nonplanning impulsivity in young adult heavy drinkers Addictive Behaviors
37 (4), 420-426.
Peters EN, Torres E, Toll BA, Cummings KM, Gritz ER, Hyland A, Herbst RS, Marshall JR, Warren GW (2012). Tobacco assessment in actively accruing National Cancer Institute Cooperative Group Program Clinical Trials Journal of Clinical Oncology
30 (23), 2869-2875.
Reback CJ, Grant DL, Fletcher JB, Branson CM, Shoptaw S, Bowers JR, Charania M, Mansergh G (2012). Text messaging reduces HIV risk behaviors among methamphetamine-using men who have sex with men AIDS and Behavior
16 (7), 1993-2002.
Reback CJ, Peck JA, Fletcher JB, Nuno M, Dierst-Davies R (2012). Lifetime substance use and HIV sexual risk behaviors predict treatment response to contingency management among homeless, substance-dependent MSM Journal of Psychoactive Drugs
44 (2), 166-172.
Reback CJ, Shoptaw S, Downing MJ (2012). Prevention case management improves socioeconomic standing and reduces symptoms of psychological and emotional distress among transgender women AIDS Care
24 (9), 1136-1144.
Schwartz RP, Kelly SM, O’Grady KE, Gandhi D, Jaffe JH (2012). Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings Addiction
107 (5), 943-952. [PMCID: PMC3319854].
Wiechelt SA, Gryczynski J, Johnson JL, Caldwell D (2012). Historical trauma among urban American Indians: Impact on substance abuse and family cohesion Journal of Loss and Trauma
17 (4), 319-336.
Wilson ME, Kinlock TW, Gordon MS, O’Grady KE, Schwartz RP (2012). Post-prison release HIV-risk behaviors in a randomized trial of methadone treatment for prisoners The American Journal on Addictions
21 (5), 476-487.
Wilson ME, Kinlock TW, Gordon MS, O’Grady KE, Schwartz RP (2012). Post-prison HIV-risk behaviors in a randomized clinical trial of methadone maintenance treatment American Journal on Addictions
21, 476-487. PMCID: PMC3422766. doi: 10.1111/j.1521-0391.2012.00250.x. PMID: 22882399. PMCID: PMC3422766.
Wilson ME, Taxman FS, O’Grady KE (2012). The relationship of social networks to HIV risk behaviors from a sample of probationers in a randomized trial The Prison Journal (PMC Journal in Process)
92 (3).
2011
Bowers JR, Branson CM, Fletcher JB, Reback CJ (2011). Differences in substance use and sexual partnering between men who have sex with men, men who have sex with men and women and transgender women Culture, Health, and Sexuality
13 (6), 629-642.
Dierst-Davies R, Reback CJ, Peck JA, Nuno M, Kamien JB, Amass L (2011). Delay discounting among homeless, out-of-treatment, substance-dependent men who have sex with men The American Journal of Drug and Alcohol Abuse
37 (2), 93-97.
Gordon MS, Kinlock TW, Miller PM (2011). Medication-assisted treatment research with criminal justice populations: challenges of implementation Behavioral Sciences and the Law
29 (6), 829-845. [PMCID: PMC3243915].
Gryczynski J, Johnson J (2011). Special issue on Native Americans and substance use Substance Use and Misuse
46 (11), 1359-1362.
Gryczynski J, Johnson JL (2011). Challenges in public health research with American Indians and other small ethnocultural minority populations. [Review] Substance Use and Misuse
46 (11), 1363-1371.
Gryczynski J, Mitchell SG, Peterson TR, Gonzales A, Moseley A, Schwartz RP (2011). The relationship between services delivered and substance use outcomes in New Mexico’s Screening, Brief Intervention, Referral and Treatment (SBIRT) Initiative Drug and Alcohol Dependence
118 (2-3), 152-157. [PMCID: PMC21482039].
Gryczynski J, Schwartz RP, Salkever DS, Mitchell SG, Jaffe JH (2011). Patterns in admission delays to outpatient methadone treatment in the United States Journal of Substance Abuse Treatment
41 (4), 431-439. [PMCID: PMC3205308].
Gryczynski J, Ward BW (2011). Social norms and the relationship between cigarette use and religiosity among adolescents in the United States Health Education and Behavior
38 (1), 39-48.
Hughes JR, Peters EN, Naud S (2011). Effectiveness of over-the-counter nicotine replacement therapy: A qualitative review of non-randomized trials Nicotine and Tobacco Research
13 512-522.
Johnson JL, Gryczynski J, Moe J (2011). Treatment issues and interventions with young children and their substance-abusing parents. In SLA Straussner & CH Fewell (Eds.) Children of Substance Abusing Parents: Dynamics and Treatment
(pp. 101-125). New York: Springer.
Katz EC, Brown BS, Schwartz RP, O’Grady KE, King SD, Gandhi D (2011). Transitioning opioid-dependent patients from detoxification to long-term treatment: Efficacy of intensive role induction Drug and Alcohol Dependence
117 (1), 24-30. [PMCID: PMC3090541].
Kelly SM, O’Grady KE, Mitchell SG, Brown BS, Schwartz RP (2011). Predictors of methadone treatment retention from a multi-site study: A survival analysis. Drug and Alcohol Dependence
117. (2-3), 170-175. [PMCID: PMC3148301].
Kinlock TW (2011). Commentary on Huang et al.: New questions and directions for future research emanating from an evaluation of the effectiveness of a harm reduction program Addiction
106 1446-1447.
Kinlock TW, Gordon MS, Schwartz RP (2011). Incarcerated populations. In P. Ruiz & E. Strain (Eds.) Lowinson & Ruiz’s Substance Abuse: A Comprehensive Textbook
(Fifth ed., pp. 881-891). Philadelphia, PA: Lippincott Williams & Wilkins.
Mitchell SG, Morioka R, Reisinger HS, Peterson JA, Kelly SM, Agar MH, Schwartz RP, et al (2011). Redefining retention: recovery from the patient’s perspective Journal of Psychoactive Drugs
43 (2), 99-107. [PMCID: PMC3160714].
Peters EN, Nich C, Carroll KM (2011). Primary outcomes in two randomized controlled trials of treatments for cannabis use disorders Drug and Alcohol Dependence
118 (2-3), 408-416.
Reback CJ, Shoptaw S (2011). Development of an evidence-based, gay-specific cognitive behavioral therapy intervention for methamphetamine-abusing gay and bisexual men Addictive Behaviors
[Epub ahead of print].
Rich JD, McKenzie M, Dickman S, Bratberg J, Lee JD, Schwartz RP (2011). An Adverse Reaction to Buprenorphine/Naloxone Induction in Prison: A Case Report Addictive Disorders and their Treatment
10 (4), 199-200. PMCID: PMC3222590.
Schwartz RP, Kelly SM, O’Grady KE, Gandhi D, Jaffe JH (2011). Interim methadone treatment compared to standard methadone treatment: 4-Month findings Journal of Substance Abuse Treatment
41 (1), 21-29. [PMCID: PMC3110526].
Schwartz RP, Kelly SM, O’Grady KE, Mitchell SG, Brown BS (2011). Antecedents and correlates of methadone treatment entry: a comparison of out-of-treatment and in-treatment cohorts Drug and Alcohol Dependence
115 (1-2), 23-29. [PMCID: PMC3059350].
Schwartz RP, Mitchell SG, Gordon MS, and Kinlock TW (2011). Pharmocotherapy. In C. Leukefeld, J. Gregrich & T. P. Gullotta (Eds.), Handbook on Evidence-Based Substance Abuse Treatment Practice in Criminal Justice Settings, Issues in Childrens’ and Families’ Lives 11
(pp. 259-277). New York: Springer Publishing.
Wiechelt SA, Gryczynski J (2011). Cultural and historical trauma among Native Americans. In S. Ringel & J. R. Brandell (Eds.), Trauma: Contemporary Directions in Theory, Practice, and Research
(pp. 191-222). Thousand Oaks, CA: Sage.
2010
Della LJ, DeJoy DM, Mitchell SG, Goetzel RZ, Chung-Roemer E, Wilson MG (2010). Management support and workplace health promotion: Field test of the Leading by Example (LBE) assessment tool American Journal of Health Promotion
25 (2), 138-146.
Gryczynski J, Feldman R, Carter-Pokras O, Kanamori M, Chen L, Roth S (2010). Contexts of tobacco use and perspectives on smoking cessation among a sample of urban American Indians Journal of Health Care for the Poor and Underserved
21 (2), 544-558.
Hughes JR, Solomon LJ, Livingston AE, Callas PW, Peters EN (2010). A randomized controlled trial of NRT-assisted gradual vs. abrupt smoking cessation Drug and Alcohol Dependence
111 105-113.
Johnson BA, Elkashef AM, Seneviratne C, Ait-Dauod N, Kahn RC, Li SH, Bloch DA, Holmes TH, Wang XQ, Vocci FJ, Jr Li MD, and the Methamphetamine Study Group (2010). Association between genotype of the serotonin transporter linked polymorphic region of the serotonin transporter gene and age of onset of methamphetamine use: a preliminary analysis Frontiers in Psychiatry
1, 145.
Johnson JL, Baldwin J, Gryczynski J, Wiechelt SA, Haring RC (2010). The Native American experience: From displacement and cultural trauma to resilience. In H. McCubbin, K. Ontai, L. Kehl, et al. (Eds.), Multiethnicity and Multiethnic Families: Development, Identity, and Resilience
(pp. 277-301). Honolulu, HI: Le’A Publications.
Kelly SM, O’Grady KE, Brown BS, Mitchell SG, Schwartz RP (2010). The role of patient satisfaction in methadone treatment. American Journal of Drug and Alcohol Abuse, 36
(3), 150-154. [PMCID: PMC2938880].
Kelly SM, O’Grady KE, Schwartz RP, Peterson JA, Wilson ME, Brown BS (2010). The relationship of social support to treatment entry and engagement: The community assessment inventory Substance Abuse
31 (1), 43-52. [PMCID: PMC2856126].
Kinlock TW, Gordon MS, Schwartz RP, Fitzgerald TT (2010). Developing and implementing a new prison-based buprenorphine treatment program Journal of Offender Rehabilitation
49 (2), 91-109. [PMCID: PMC2868193].
Mitchell SG, Lounsbury D (2010). Community Psychology. In C. S. Clauss-Ehlers (Ed.) Encyclopedia of Cross-Cultural School Psychology
(pp. 249-256). New York, NY: Springer.
Peters EN, Hughes JR (2010). Daily marijuana users with past alcohol problems increase alcohol consumption during marijuana abstinence Drug and Alcohol Dependence
106 (2-3), 111-118.
Peterson JA, Schwartz RP, Mitchell SG, Reisinger HS, Kelly SM, O’Grady KE, Brown BS, Agar MH (2010). Why don’t out-of-treatment individuals enter methadone treatment programs? International Journal of Drug Policy
21 36-42. [PMCID: PMC2790538].
Reback CJ, Larkins S (2010). Maintaining a heterosexual identity: Sexual meanings among a sample of heterosexually identified men who have sex with men Archives of Sexual Behavior
39 (3), 766-773.
Reback CJ, Ling D, Shoptaw S, Rohde J (2010). Developing a Text Messaging Risk Reduction Intervention for Methamphetamine-Using MSM: Research Note The Open AIDS Journal
4 116-122.
Reback CJ, Peck JA, Dierst-Davies R, Nuno M, Kamien JB, Amass A (2010). Contingency management among homeless, out-of-treatment men who have sex with men Journal of Substance Abuse Treatment
39 (3), 255-263.
Wilson ME, Schwartz RP, O’Grady KE, Jaffe JH (2010). Impact of interim methadone maintenance on HIV risk behaviors Journal of Urban Health
87 (4), 586-591. [PMCID: PMC2900571].
2009
Anderson AL, Reid MS, Li SH, Holmes T, Shemanski L, Slee A, Smith EV, Kahn R, Chiang N, Vocci F, Ciraulo DD, Ackis C, Roache JD, Salloum IM, Somoza E, Urschel HC 3rd, Elkashef AM (2009). Modafinil for the treatment of cocaine dependence Drug and Alcohol Dependence
104(1-2), 133-139.
Carswell, S.B., Hanlon TE, O’Grady KE, Watts A, Pothhong P (2009). A preventive intervention program for urban African American youth attending an alternative education program: Background, implementation, and feasibility. Education and Treatment of Children
Chandler RK, Dennis ML, El-Bassel N, Schwartz RP, Field G (2009). Ensuring safety, implementation and scientific integrity of clinical trials: less from the Criminal Justice-Drug Abuse Treatment Studies Data and Safety Monitoring Board Journal of Experimental Criminology
5(3), 324-244.
Frye V, Fortin P, MacKenzie S, Purcell D, Edwards LV, Mitchell SG, Valverde E, Garfein RS, Metsch L, Latka MH (2009). Managing identity impacts associated with disclosure of HIV status: A qualitative investigation AIDS Care
21(8), 1071-1078.
Gryczynski J, Schwartz RP, O’Grady K, Jaffe JH (2009). Dropout from interim methadone and subsequent comprehensive methadone maintenance American Journal of Drug and Alcohol Abuse
35, 394-398.
Gryczynski J, Schwartz RP, O’Grady K, Jaffe JH (2009). Treatment entry among individuals on a waiting list for methadone maintenance. American Journal of Drug and Alcohol Abuse
35(5), 290-294. Abstract.
Hanlon TE, Simon BD, O’Grady KE, Carswell, S.B., Callaman JM (2009). The effectiveness of an after-school program targeting urban African American youth. Education and Urban Society
In J M Roll RA Rawson W Ling and SShoptaw (Eds) Vocci FJ, Elkashef E, Appel NM (2009). Pharmacological treatment of methamphetamine addiction Methamphetamine addiction: From basic science to treatment
(pp 202-229) New York: Guilford Press.
Johanson CE, Balster RL, Henningfield JE, Schuster CR, Anthony JC, Barthwell AG, Coleman JJ, DArt R, Gorodetzky CW, O’Keeffe C, Sellers EM, Vocci F, Walsh SL (2009). Risk-management and post-marketing surveillance for the abuse of medications acting on the central nervous system: expert panel report Drug and Alcohol Dependence
105(Suppl 1), 565-571.
Katz EC, Schwartz RP, King SD, Highfield DA, O’Grady KE, Billings T, Gandhi D, Weintraub E, Glovinsky D, Barksdale W, Brown BS (2009). Brief v. extended buprenorphine detoxification in a community treatment program: Engagement and short-term outcomes. American Journal of Drug and Alcohol Dependence
Kelly SM, Schwartz RP, O’Grady KE, Mitchell SG, Reisinger HS, Peterson JA, Agar MH, Brown BS (2009). Gender differences among in- and out-of-treatment opioid-addicted individuals. American Journal of Drug and Alcohol Abuse
35, 38-42.
Kinlock TW, Gordon MS, Schwartz RP, Fitzgerald TT, O’Grady KE (2009). Methadone maintenance for prisoners: Results at twelve-months post-release. Journal of Substance Abuse Treatment
37, 277-285.
Kinlock TW, Sears EA, O’Grady KE, Callaman JM, Brown BS (2009). Treatment retention and changes in motivation among drug court probationers. Journal of Offender Rehabilitation
Lounsbury DW Mitchell SG (2009). Introduction to special issue on social ecological approaches to community health research and action American Journal of Community Psychology
44(3/4), 213-220. doi: 10.1007/s10464-009-9266-4. PMID: 19777338.
Mitchell SG, Kelly SM, Brown BS, Reisinger HS, Peterson JA, Ruhf A, Agar MH, O’Grady KE Schwartz RP (2009). Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland. The American Journal on Addictions
Mitchell SG, Kelly SM, Brown BS, Reisinger HS, Peterson JA, Ruhf A, Agar MH, Schwartz RP (2009). Incarceration and opioid withdrawal: The experiences of methadone patients and out-of-treatment heroin users. Journal of Psychoactive Drugs
Schnavia H, Toldson I, Godette D, Richardson J (2009). Mental Health, Substance Abuse, and HIV Disparities in Correctional Settings: Practice and Policy Implications for African Americans Journal of Health Care for the Poor and Underserved
Schwartz RP, Jaffe JH, O’Grady K, Das B, Highfield DA, Wilson ME (2009). Scaling-up interim methadone maintenance: Treatment for 1,000 heroin addicts Journal of Substance Abuse Treatment
37(4), 362-367. PMCID: PMC2796977.
Schwartz RP, Jaffe JH, O’Grady KE, Kinlock TW, Gordon MS, Kelly SM, Wilson ME, Ahmed A (2009). Interim Methadone Treatment: Impact on Arrests. Drug and Alcohol Dependence
103, 148-154. doi: 10.1016/j.drugalcdep.2009.03.007. Epub 2009 May 14. PMID: 19443133.
Vocci FJ, Montoya ID (2009). Psychological treatments for stimulant misuse: comparing and contrasting those for amphetamine dependence and those for cocaine dependence Current Opinion in Psychiatry
23(3), 263-268.
Ward B, Gryczynski J (2009). Social learning theory and the effects of living arrangement on heavy alcohol use: Results from a national study of college students. Journal of Studies on Alcohol
70, 364-372.
Wiechelt SA, Gryczynski J, Johnson JL (2009). Designing HIV preventative interventions for urban American Indians: Evolution of ‘The Don’t Forget Us’ program Health & Social Work
34(4), 301-304.
2008
Elkashef A, Vocci F, Hanson G, White J, Wickes W, Tiihonen J, Acri J (2008). Pharmacotherapy of methamphetamine addiction: An update Substance Abuse
29(3), 31-50. PMCID: PMC2597382.
Elkashef AM, Rawson RA, Anderson AL, Li SH, Holmes T, Smith EV, Chiang N, Kahn R, Vocci F, Ling W, Pearce VL, McCann M, Campbell J, Gorodetzky C, Haning W, Carlton B, Mawhinney J, Weis D (2008). Bupropion for the treatment of methamphetamine dependence Neuropsychopharmacology
33(5), 1162-1170.
Friedmann PD, Katz EC, Rhodes AG, Taxman FS, O’Connell DJ, Frisman LK, Burdon WM, Fletcher BW, Litt MD, Martin SS (2008). Collaborative Behavioral Management for Drug-Involved Parolees: Rationale and Design of the Step’N Out Study. Journal of Offender Rehabilitation
47, 290-318.
Gordon MS, Kinlock TW, Schwartz RP, O’Grady KE (2008). A randomized clinical trial of methadone maintenance for prisoners: Findings at 6-months post-release Addiction
103 (8), 1333-1342.
Johnson BA, Ait-Daoud N, Elkashef AM, Smith EV, Kahn R, Vocci F, Li SH, Bloch DA (2008). Methamphetamine Study Group: a preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence The International Journal of Neuropsychopharmacology
11(1), 1-17.
Kinlock TW, Gordon MS, Schwartz RP, O’Grady KE (2008). A study of methadone maintenance for male prisoners: Three-month post-release outcomes Criminal Justice and Behavior
35 (1), 34-47.
Marsella A, Johnson J, Watson P, Gryczynski J, Eds (2008). Ethnocultural Perspectives on Disaster and Trauma: Foundations, Issues, and Applications New York, Springer
Mitchell SG, Goetzel RZ, Ozminkowski RJ (2008). The value of worksite health promotion. ACSM’s Heath and Fitness Journal
12(2), 23-27.
Peterson JP, Schacht-Reisinger H, Schwartz RP, Mitchell SG, Kelly SM, Brown BS, Agar MH (2008). Targeted sampling in drug abuse research: A review and case study. Field Methods
20(2), 155-170.
Reback CJ, Shoptaw S, Grella CE (2008). Methamphetamine use trends among street-recruited Gay and Bisexual males, from 1999 to 2007 Journal of Urban Health
85(6): 874-879.
Reisinger HS, Schwartz RP, Mitchell SG, Peterson JA, Kelly SM, O’Grady KE, Marrari EA, Brown BS, Agar MH (2008). Premature discharge from methadone treatment: Patient perspectives Journal of Psychoactive Drugs
Schwartz RP, Kelly SM, O’Grady KE, Mitchell SG, Peterson JA, Reisinger HS, Agar MH, Brown BS (2008). Attitudes toward buprenorphine and methadone among opioid-dependent individuals. American Journal on Addictions
17(5), 396-401.
Schwartz RP, Kelly SM, O’Grady KE, Peterson JA, Reisinger HS, Mitchell SG, Wilson ME, Agar MH, Brown BS (2008). In-treatment v. out-of-treatment opioid dependent adults: Drug use and criminal history. American Journal of Drug and Alcohol Abuse
34(1), 17-28.
Shoptaw S, Reback C, Larkins S, Wang J, Rotheram-Fuller E, Dang J, Yang X (2008). Outcomes using two tailored behavioral treatments for substance abuse in urban Gay and Bisexual Men. Journal of Substance Abuse Treatment
35(3): 285-293.
Shoptaw S, Rotheram-Fuller E, Landovitz R, Wang J, Moe A, Reback CJ, Kanouse D (2008). Non-occupational post exposure prophylaxis as a biobehavioral HIV prevention intervention. AIDS Care
20(3): 376-381.
Somoza E, Somoza P, Lewis D, Li SH, Winhusen T, Chiang N, Vocci F, Horn P, Elkashef E (2008). A new outcome measure for use in pharmacotherapy trials for cocaine dependence Drug and Alcohol Dependence
93, 132-140.
Vocci F (2008). Cognitive remediation in the treatment of substance abuse disorders: A research agenda Experimental and Clinical Psychopharmacology
6(6), 484-497.